UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): AUGUST 27, 2009
ISOLAGEN, INC.
(Exact name of registrant as specified in its charter)
         
DELAWARE   001-31564   87-0458888
         
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer Identification No.)
     
405 EAGLEVIEW BLVD., EXTON, PA
   
19341
     
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (484) 713-6000
NOT APPLICABLE
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


 

Item 1.03 Bankruptcy Or Receivership
As previously reported, on June 15, 2009 Isolagen, Inc. (the “Company”) and the Company’s wholly owned subsidiary, Isolagen Technologies, Inc. (“Isolagen Tech”) (the Company and Isolagen Tech are referred as the “Debtors”), each filed a voluntary petition for reorganization under chapter 11 of the United States Bankruptcy Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Delaware in Wilmington (the “Bankruptcy Court”) under Case Nos. 09-12072 and 09-12073, respectively. The Company and Isolagen Tech continue to manage and operate their business as debtors in possession pursuant to Bankruptcy Code sections 1107 and 1108.
On August 27, 2009 (the “Confirmation Date”), the Bankruptcy Court entered an order (the “Confirmation Order”) confirming the Debtors’ Joint First Amended Plan of Reorganization dated July 30, 2009, as supplemented by the Plan Supplement dated August 21, 2009 (as so modified and supplemented, the “Plan”). Copies of the Debtors’ First Amended Joint Plan of Reorganization dated July 30, 2009, the Plan Supplement and the exhibits to the Plan Supplement are filed as exhibits to this Report and are incorporated herein by this reference.
The following is a summary of the material matters contemplated to occur either pursuant to or in connection with the confirmation and implementation of the Plan. This summary only highlights certain of the substantive provisions of the Plan and is not intended to be a complete description of, or a substitute for a full and complete reading of, the Plan. This summary is qualified in its entirety by reference to the full text of the Plan. Capitalized terms used but not defined in this Form 8-K have the meanings set forth in the Plan.
Plan of Reorganization
A. Implementation of the Plan
1.  Effective Date . On the date all of the conditions precedent to confirmation and consummation of the Plan are satisfied or waived (the “Effective Date”), the Company will emerge from bankruptcy as a company named “Fibrocell Science, Inc.”
2.  New Board of Directors . On the Effective Date, the Company’s current officers and directors shall be deemed to have resigned and a new board of directors shall be determined by the DIP Lenders and the Plan Funders. The initial board of directors of the Company shall consist of David Pernock, Paul Hopper and Kelvin Moore. Declan Daly shall remain as an executive officer of the Company.
3.  Exit Financing . On the Effective Date, the Company will issue New Common Stock to the Plan Funders in exchange for $2 million to fund the Reorganized Debtors’ continued operations and the distributions that the Reorganized Debtors must make pursuant to the terms of the Plan.
4.  Equity Holders . As discussed below, all equity interests in the Company, including without limitation common stock, options and warrants, will be cancelled. Upon the Effective Date, the Company intends to complete an Exit Financing of common stock in the amount of $2 million, after which the equity holders in the Company shall be: (i) 7,320,000 shares, or 49.91%, to the Pre-Petition Lender Claims and DIP Facility Claims, collectively; (ii) 3,960,000 shares, or 27%, to the 3.5% Convertible Noteholders; (iii) 600,000 shares, or 4.09%, to Management; (iv) 120,000 shares, or 0.82%, to the General Unsecured Claims; and (v) 2,666,666 shares, or 18.18%, for the Exit Financing (the Pre-Petition Lender Claims, DIP Lenders and 3.5% Convertible Noteholders shall have the right to participate in the Exit Financing; the percentages in (i) and (ii) assume full funding of the Exit Financing and no participation by any of the listed creditor classes). Upon the completion of the Exit Financing, the Company will have a total of 14,666,666 shares outstanding. Distribution of such New Common Stock shall be made by delivery of one or more certificates representing such shares as described herein or made by means of book-entry exchange through the facilities of DTC in accordance with the customary practices of DTC. To the extent prohibited by Section 1123(a)(6) of the Bankruptcy Code, the Company will not issue nonvoting equity securities; provided, however the foregoing restriction will (a) have no further force and effect beyond that required under Section 1123 of the Bankruptcy Code, (b) only have such force and effect for so long as Section 1123 of the Bankruptcy Code is in effect and applicable to the Company, and (c) in all events may be amended or eliminated in accordance with

 

 


 

applicable law as from time to time may be in effect. The Certificate of Incorporation and By-Laws will set forth the rights and preferences under the New Common Stock.
5.  Management Incentive Plan . The management team of the Reorganized Debtors and their subsidiaries shall receive 5% of the New Common Stock, subject to dilution by the Exit Financing. The management team’s equity state shall be subject to a two-year vesting schedule whereby 50% shall vest on the Effective Date, 25% shall vest on the first anniversary, and 25% shall vest on the second anniversary.
6.  Assets and Liabilities . The assets and liabilities of the Company as the date of the Confirmation Order are as set forth in the Plan and Disclosure Statement filed with the Bankruptcy Court, which is attached hereto.
B. Treatment of Claims and Interests
1.  Class 1 — Pre-Petition Lender Claims : Subject to and pursuant to the terms of the Plan, the Holders of the Allowed Pre-Petition Lender Claims have agreed that, in lieu of accepting Cash on account of their Allowed Pre-Petition Lender Claims, the Pre-Petition Lenders shall receive, together with the DIP Lenders as set forth in Section 3.06 of the Plan, their Pro Rata share of up to 61% of the New Common Stock of the Company, subject to dilution by the Exit Financing. The DIP Lenders and the Pre-Petition Lenders have also agreed to compensate Viriathus or its assignee 10% of its Pro Rata Distribution of the New Common Stock.
2.  Class 2 — Other Secured Claims : On the Distribution Date, each Holder of an Allowed Class 2 Claim shall receive in full satisfaction, settlement, release and discharge of and in exchange for such Allowed Other Secured Claim and at Debtors’ exclusive election, either: (i) Cash equal to the amount of such Allowed Other Secured Claim, or (ii) the Collateral which serves as security for such Allowed Other Secured Claim, except to the extent that any Holder of an Allowed Other Secured Claim agrees to less favorable treatment thereof.
3.  Class 3—3.5% Convertible Notes : Each Holder of an Allowed 3.5% Noteholder Claim shall receive, in full and final satisfaction, settlement, release and discharge of and in exchange for such Allowed 3.5% Noteholder Claim the following:
(a) its Pro Rata share of an unsecured note in the principal amount of $6 million (the “New Note”). The New Note shall have the following features: (1) 12.5% interest payable quarterly in Cash or, at the Company’s option, 15% payable in kind (“PIK”) by capitalizing such unpaid amount and adding it to the principal as of the date it was due; (2) maturing June 1, 2012; (3) at any time prior to the maturity date, the Company may redeem any portion of the outstanding principal of the New Notes in Cash at 125% of the stated face value of the New Notes; provided that the Company will be obligated to redeem all outstanding New Notes upon the following events: (a) the Debtors successfully complete a capital campaign raising in excess of $10,000,000; or (b) the Debtors are acquired by, or sell a majority stake to, an outside party; (4) the New Notes contain customary representations, warranties and covenants, including a covenant that the Debtors shall be prohibited from the incurrence of additional debt without obtaining the consent of 66 2 / 3 % of the New Note holders.
(b) its Pro Rata share of 33% of the New Common Stock subject to dilution by the Exit Financing.
(c) The Plan allows the 3.5% Noteholder Claims in the amount of the outstanding principal and accrued and unpaid interest as of the Petition Date in the approximate aggregate amount of $81 million (plus any other amounts due under the indenture and allowable under the Bankruptcy Code).
4.  Class 4—General Unsecured Claims : Each holder of an Allowed General Unsecured Claim shall, in full and final satisfaction, settlement, release and discharge of and in exchange for such Allowed General Unsecured Claim, be paid their Pro Rata portion of 1% of the New Common Stock, subject to dilution by the Exit Financing.
5.  Class 5—Old Common Stock : On the Effective Date, all Interests in Old Common Stock (which include options, warrants and other convertible securities) shall be cancelled and extinguished under the Plan, and the Holders thereof shall neither retain nor receive any distribution of property or Assets on account of their Interests.

 

 


 

6.  Class 6—Intercompany Claims : No distributions shall be made under the Plan on account of Intercompany Claims, and any and all liability on account of such Intercompany Claims shall be deemed discharged.
7.  Treatment of Administrative Claims, Priority Tax and Non-Tax Claims : Administrative Expense Claims are not impaired under the Plan. Each Holder of an Allowed Administrative Expense Claim, shall, in full and final satisfaction, release and discharge of and in exchange for such Allowed Administrative Expense Claim, be paid either (i) in Cash or (ii) on such other terms and conditions as may be agreed between the Holder of the Allowed Administrative Expense Claim the Debtors and/or the Reorganized Debtors, and the Agent. Priority Non-Tax Claims are not impaired under the Plan. Each Holder of an Allowed Priority Non-Tax Claim shall, in full and final satisfaction, settlement, release and discharge of and in exchange for such Allowed Priority Non-Tax Claim, receive Cash in the amount of the Allowed Priority Non- Tax Claim, except to the extent that any Holder of an Allowed Priority Non-Tax Claim agrees to less favorable treatment thereof. Priority Tax Claims are not impaired under the Plan. Each Holder of an Allowed Priority Tax Claim shall, in full and final satisfaction, settlement, release and discharge of and in exchange for such Allowed Priority Tax Claim, be paid in full through deferred Cash payments in an aggregate principal amount equal to the amount of the Allowed Priority Tax Claim plus interest on the unpaid portion at the rate of 4% per annum from the Effective Date through the date of payment thereof which may be as long as 5 years from the order for relief in the bankruptcy cases, except to the extent that any Holder of an Allowed Priority Tax Claim agrees to less favorable treatment thereof.
Item 9.01 Financial Statements and Exhibits.
(d)  
Exhibits
     
2.1
  Debtors’ First Amended Joint Plan of Reorganization dated July 30, 2009 (filed as Exhibit 10.2 to the Company’s Form 10-Q for quarter ended June 30, 2009, filed on August 12, 2009)
3.1
  Amended and Restated Certificate of Incorporation
3.2
  Amended and Restated Bylaws
99.1
  Disclosure Statement
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  ISOLAGEN, INC.
 
 
Date: September 2, 2009  By:   /s/ Declan Daly    
    Declan Daly,   
    Chief Executive Officer   
 

 

 

Exhibit 3.1
AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
ISOLAGEN, INC.
Isolagen, Inc., a corporation existing under the laws of the State of Delaware, hereby certifies as follows:
A. The name of the corporation is Isolagen, Inc. The corporation was originally incorporated under the name American Financial Holding, Inc., and the original Certificate of Incorporation of the corporation was filed with the Secretary of State of the State of Delaware on September 28, 1992.
B. A Certificate of Merger was filed with the Secretary of State of Delaware on October 2, 1992, merging American Financial Holding, Inc., a Colorado corporation, with and into American Financial Holding Inc., under the name American Financial Holding, Inc.
C. Certificates of Designation were filed with the Secretary of State of Delaware on April 19, 2002, May 8, 2003, and May 15, 2006.
D. Certificates of Amendments were filed with the Secretary of State of Delaware on July 5, 2001, November 13, 2001, August 11, 2003, and June 30, 2005.
E. This Amended and Restated Certificate of Incorporation restates, integrates and amends the Certificate of Incorporation of this corporation.
C. This Amended and Restated Certificate of Incorporation was directed by an order of the United States Bankruptcy Court for the District of Delaware in accordance with the applicable provisions of section 303 of the General Corporation Law of the State of Delaware.
D. The text of the Certificate of Incorporation of the corporation is hereby amended and restated in its entirety to read as follows:
Article I
Name
The name of the corporation (the “Corporation”) is Fibrocell Science, Inc.
Article II
Duration
The Corporation shall continue in existence perpetually unless sooner dissolved according to law.

 

 


 

Article III
Purposes
The purposes for which the Corporation is organized are to engage in any lawful purposes, activities, and pursuits for which corporations may be organized under the General Corporation Law of Delaware and to exercise all powers allowed or permitted thereunder.
Article IV
Capitalization
The Corporation shall have authority to issue an aggregate of 255,000,000 shares, of which 5,000,000 shares shall be preferred stock, $0.001 par value (hereinafter the “Preferred Stock”), and 250,000,000 shares shall be common stock, par value $0.001 (hereinafter the “Common Stock”). To the extent prohibited by Section 1123(a)(6) of Chapter 11 of Title 11 of the United States Code (the “Bankruptcy Code”), the Corporation will not issue nonvoting equity securities; provided, however the foregoing restriction will (a) have no further force and effect beyond that required under Section 1123 of the Bankruptcy Code, (b) only have such force and effect for so long as Section 1123 of the Bankruptcy Code is in effect and applicable to the Corporation, and (c) in all events may be amended or eliminated in accordance with applicable law as from time to time may be in effect. The powers, preferences and rights, and the qualifications, limitations or restrictions thereof, of the shares of stock of each class and series which the Corporation shall be authorized to issue, are as follows:
1.  
Preferred Stock . Shares of Preferred Stock may be issued from time to time in one or more series as may from time to time be determined by the board of directors. Each series shall be distinctly designated. All shares of any one series of the Preferred Stock shall be alike in every particular, except that there may be different dates from which dividends thereon, if any, shall be cumulative, if made cumulative. The powers, preferences, participating, optional and other rights of each such series and qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding.
  A.  
Authority of the Board of Directors. Except as hereinafter provided, the board of directors of this Corporation is hereby expressly granted authority to fix by resolution or resolutions adopted prior to the issuance of any shares of each particular series of Preferred Stock, the designation, powers, preferences and relative participating, optional and other rights and the qualifications, limitations and restrictions thereof, if any, of such series, including, without limiting the generality of the foregoing, the following:
  (i)  
the distinctive designation of and the number of shares of Preferred Stock that shall constitute each series, which number may be increased (except as otherwise fixed by the board of directors) or decreased (but not below the number of shares thereof outstanding) from time to time by action of the board of directors;
 
  (ii)  
the rate and times at which, and the terms and conditions on which, dividends, if any, on the shares of the series shall be paid; the extent of preferences or relation, if any, of such dividends to the dividends payable on any other class or classes of stock of

 

2


 

     
this Corporation or on any series of Preferred Stock; and whether such dividends shall be cumulative or noncumulative;
  (iii)  
the right, if any, of the holders of the shares of the same series to convert the same into, or exchange the same for, any other class or classes of stock of this Corporation and the terms and conditions of such conversion or exchange;
 
  (iv)  
whether shares of the series shall be subject to redemption and the redemption price or prices, including, without limitation, a redemption price or prices payable in shares of any other class or classes of stock of the Corporation, cash or other property and the time or times at which, and the terms and conditions on which, shares of the series may be redeemed;
 
  (v)  
the rights, if any of the holders of shares of the series on voluntary or involuntary liquidation, merger, consolidation, distribution or sale of assets, dissolution or winding up of this Corporation;
 
  (vi)  
the terms of the sinking fund or redemption or purchase account, if any, to be provided for shares of the series; and
 
  (vii)  
the voting powers, if any, of the holders of shares of the series which may, without limiting the generality of the foregoing, include (1) the right to more or less than one vote per share on any or all matters voted on by the stockholders, and (2) the right to vote as a series by itself or together with other series of Preferred Stock or together with all series of Preferred Stock as a class, on such matters, under such circumstances, and on such conditions as the board of directors may fix, including, without limitation, the right, voting as a series by itself or together with other series of Preferred Stock or together with all series of Preferred Stock as a class, to elect one or more directors of this Corporation in the event there shall have been a default in the payment of dividends on any one or more series of Preferred Stock or under such other circumstances and upon such conditions as the board of directors may determine.
  B.  
Preferred Class C Stock . The Series C Junior Participating Preferred Stock shall consist of the following:
  (i)  
Designation and Amount. The shares of the series of Preferred Stock shall be designated as “Series C Junior Participating Preferred Stock,” $0.001 par value per share, and the number of shares constituting such series shall be 10,000.
  (ii)  
Dividends and Distributions.
  (a)  
The holders of shares of Series C Junior Participating Preferred Stock shall be entitled to receive, when, as and if declared by the Board of Directors out of funds legally available for the purpose, quarterly dividends payable in cash on the fifteenth day of February, May, August and November in each year (each such date being referred to herein as a “Quarterly Dividend Payment Date”), commencing on the first Quarterly Dividend Payment Date after the first issuance

 

3


 

     
of a share or fraction of a share of Series C Junior Participating Preferred Stock, in an amount per share (rounded to the nearest cent) equal to the greater of (a) $1,000.00 or (b) subject to the provision for adjustment hereinafter set forth, 10,000 times the aggregate per share amount of all cash dividends, and 10,000 times the aggregate per share amount (payable in kind) of all non-cash dividends or other distributions other than a dividend payable in shares of Common Stock or a subdivision of the outstanding shares of Common Stock (by reclassification or otherwise), declared on the Common Stock, par value $0.001 per share, of the Corporation (the “Common Stock”) since the immediately preceding Quarterly Dividend Payment Date, or, with respect to the first Quarterly Dividend Payment Date, since the first issuance of any share or fraction of a share of Series C Junior Participating Preferred Stock. In the event the Corporation shall at any time after May 12, 2006 (the “Rights Declaration Date”) (i) declare any dividend on Common Stock payable in shares of Common Stock, (ii) subdivide the outstanding Common Stock, or (iii) combine the outstanding Common Stock into a smaller number of shares, then in each such case the amount to which holders of shares of Series C Junior Participating Preferred Stock were entitled immediately prior to such event under clause (b) of the preceding sentence shall be adjusted by multiplying such amount by a fraction the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.
  (b)  
The Corporation shall declare a dividend or distribution on the Series C Junior Participating Preferred Stock as provided in paragraph (a) above immediately after it declares a dividend or distribution on the Common Stock (other than a dividend payable in shares of Common Stock); provided that, in the event no dividend or distribution shall have been declared on the Common Stock during the period between any Quarterly Dividend Payment Date and the next subsequent Quarterly Dividend Payment Date, a dividend of $1,000.00 per share on the Series C Junior Participating Preferred Stock shall nevertheless be payable on such subsequent Quarterly Dividend Payment Date.
 
  (c)  
Dividends shall begin to accrue and be cumulative on outstanding shares of Series C Junior Participating Preferred Stock from the Quarterly Dividend Payment Date next preceding the date of issue of such shares of Series C Junior Participating Preferred Stock, unless the date of issue of such shares is prior to the record date for the first Quarterly Dividend Payment Date, in which case dividends on such shares shall begin to accrue from the date of issue of such shares, or unless the date of issue is a Quarterly Dividend Payment Date or is a date after the record date for the determination of holders of shares of Series C Junior Participating Preferred Stock entitled to receive a quarterly dividend and before such Quarterly Dividend Payment Date, in either of which events such dividends shall begin to accrue and be cumulative from such Quarterly Dividend Payment Date. Accrued but unpaid dividends shall not bear interest. Dividends paid on the shares of Series C Junior Participating Preferred Stock in an amount less than the total amount of such dividends at the time accrued and payable on such shares shall be

 

4


 

     
allocated pro rata on a share-by-share basis among all such shares at the time outstanding. The Board of Directors may fix a record date for the determination of holders of shares of Series C Junior Participating Preferred Stock entitled to receive payment of a dividend or distribution declared thereon, which record date shall be no more than 30 days prior to the date fixed for the payment thereof.
  (iii)  
Voting Rights. The holders of shares of Series C Junior Participating Preferred Stock shall have the following voting rights:
  (a)  
Subject to the provision for adjustment hereinafter set forth, each share of Series C Junior Participating Preferred Stock shall entitle the holder thereof to 10,000 votes on all matters submitted to a vote of the stockholders of the Corporation. In the event the Corporation shall at any time after the Rights Declaration Date (i) declare any dividend on Common Stock payable in shares of Common Stock, (ii) subdivide the outstanding Common Stock, or (iii) combine the outstanding Common Stock into a smaller number of shares, then in each such case the number of votes per share to which holders of shares of Series C Junior Participating Preferred Stock were entitled immediately prior to such event shall be adjusted by multiplying such number by a fraction the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.
 
  (b)  
Except as otherwise provided herein or by law, the holders of shares of Series C Junior Participating Preferred Stock and the holders of shares of Common Stock shall vote together as one class on all matters submitted to a vote of stockholders of the Corporation.
  (c)  
(1)
 
If at any time dividends on any Series C Junior Participating Preferred Stock shall be in arrears in an amount equal to six (6) quarterly dividends thereon, the occurrence of such contingency shall mark the beginning of a period (herein called a “default period”) which shall extend (i) If at any time dividends on any Series C Junior Participating Preferred Stock shall be in arrears in an amount equal to six (6) quarterly dividends thereon, the occurrence of such contingency shall mark the beginning of a period (herein called a “default period”) which shall extend until such time when all accrued and unpaid dividends for all previous quarterly dividend periods and for the current quarterly dividend period on all shares of Series C Junior Participating Preferred Stock then outstanding shall have been declared and paid or set apart for payment. During each default period, all holders of Preferred Stock (including holders of the Series C Junior Participating Preferred Stock) with dividends in arrears in an amount equal to six (6) quarterly dividends thereon, voting as a class, irrespective of series, shall have the right to elect two (2) directors.
  (2)  
During any default period, such voting right of the holders of Series C Junior Participating Preferred Stock may be exercised initially at a special meeting

 

5


 

     
called pursuant to subparagraph (3) of this Section B (iii)(c) or at any annual meeting of stockholders, and thereafter at annual meetings of stockholders, provided that such voting right shall not be exercised unless the holders of ten percent (10%) in number of shares of Preferred Stock outstanding shall be present in person or by proxy. The absence of a quorum of the holders of Common Stock shall not affect the exercise by the holders of Preferred Stock of such voting right. At any meeting at which the holders of Preferred Stock shall exercise such voting right initially during an existing default period, they shall have the right, voting as a class, to elect directors to fill such vacancies, if any, in the Board of Directors as may then exist up to two (2) directors or, if such right is exercised at an annual meeting, to elect two (2) directors. If the number which may be so elected at any special meeting does not amount to the required number, the holders of the Preferred Stock shall have the right to make such increase in the number of directors as shall be necessary to permit the election by them of the required number. After the holders of the Preferred Stock shall have exercised their right to elect directors in any default period and during the continuance of such period, the number of directors shall not be increased or decreased except by vote of the holders of Preferred Stock as herein provided or pursuant to the rights of any equity securities ranking senior to or pari passu with the Series C Junior Participating Preferred Stock.
  (3)  
Unless the holders of Preferred Stock shall, during an existing default period, have previously exercised their right to elect directors, the Board of Directors may order, or any stockholder or stockholders owning in the aggregate not less than ten percent (10%) of the total number of shares of Preferred Stock outstanding, irrespective of series, may request, the calling of a special meeting of the holders of Preferred Stock, which meeting shall thereupon be called by the President, a Vice-President or the Secretary of the Corporation. Notice of such meeting and of any annual meeting at which holders of Preferred Stock are entitled to vote pursuant to this subparagraph (3) of this Section B (iii)(c) shall be given to each holder of record of Preferred Stock by mailing a copy of such notice to him at his last address as the same appears on the books of the Corporation. Such meeting shall be called for a time not earlier than 20 days and not later than 60 days after such order or request or in default of the calling of such meeting within 60 days after such order or request, such meeting may be called on similar notice by any stockholder or stockholders owning in the aggregate not less than ten percent (10%) of the total number of shares of Preferred Stock outstanding. Notwithstanding the provisions of this subparagraph (3) of this Section B (iii)(c), no such special meeting shall be called during the period within 60 days immediately preceding the date fixed for the next annual meeting of the stockholders.
  (4)  
In any default period, the holders of Common Stock, and other classes of stock of the Corporation if applicable, shall continue to be entitled to elect the whole number of directors until the holders of Preferred Stock shall have exercised their right to elect two (2) directors voting as a class, after the exercise of which right (x) the directors so elected by the holders of Preferred

 

6


 

     
Stock shall continue in office until their successors shall have been elected by such holders or until the expiration of the default period, and (y) any vacancy in the Board of Directors may (except as provided in subparagraph (2) of this Section B (iii)(c)) be filled by vote of a majority of the remaining directors theretofore elected by the holders of the class of stock which elected the director whose office shall have become vacant. References in this paragraph (c) to directors elected by the holders of a particular class of stock shall include directors elected by such directors to fill vacancies as provided in clause (y) of the foregoing sentence.
  (5)  
Immediately upon the expiration of a default period, (x) the right of the holders of Preferred Stock as a class to elect directors shall cease, (y) the term of any directors elected by the holders of Preferred Stock as a class shall terminate, and (z) the number of directors shall be such number as may be provided for in the certificate of incorporation or by-laws irrespective of any increase made pursuant to the provisions of subparagraph (2) of this Section B (iii)(c) (such number being subject, however, to change thereafter in any manner provided by law or in the certificate of incorporation or by-laws). Any vacancies in the Board of Directors effected by the provisions of clauses (y) and (z) in the preceding sentence may be filled by a majority of the remaining directors.
  (d)  
Except as set forth herein, holders of Series C Junior Participating Preferred Stock shall have no special voting rights and their consent shall not be required (except to the extent they are entitled to vote with holders of Common Stock as set forth herein) for taking any corporate action.
  (iv)  
Certain Restrictions.
  (a)  
Whenever quarterly dividends or other dividends or distributions payable on the Series C Junior Participating Preferred Stock as provided in paragraph (ii) of this Section B are in arrears, thereafter and until all accrued and unpaid dividends and distributions, whether or not declared, on shares of Series C Junior Participating Preferred Stock outstanding shall have been paid in full, the Corporation shall not (i) declare or pay dividends on, make any other distributions on, or redeem or purchase or otherwise acquire for consideration any shares of stock ranking junior (either as to dividends or upon liquidation, dissolution or winding up) to the Series C Junior Participating Preferred Stock;
  (1)  
declare or pay dividends on or make any other distributions on any shares of stock ranking on a parity (either as to dividends or upon liquidation, dissolution or winding up) with the Series C Junior Participating Preferred Stock, except dividends paid ratably on the Series C Junior Participating Preferred Stock and all such parity stock on which dividends are payable or in arrears in proportion to the total amounts to which the holders of all such shares are then entitled;

 

7


 

  (2)  
redeem or purchase or otherwise acquire for consideration shares of any stock ranking on a parity (either as to dividends or upon liquidation, dissolution or winding up) with the Series C Junior Participating Preferred Stock, provided that the Corporation may at any time redeem, purchase or otherwise acquire shares of any such parity stock in exchange for shares of any stock of the Corporation ranking junior (either as to dividends or upon dissolution, liquidation or winding up) to the Series C Junior Participating Preferred Stock; or
 
  (3)  
purchase or otherwise acquire for consideration any shares of Series C Junior Participating Preferred Stock, or any shares of stock ranking on a parity with the Series C Junior Participating Preferred Stock, except in accordance with a purchase offer made in writing or by publication (as determined by the Board of Directors) to all holders of such shares upon such terms as the Board of Directors, after consideration of the respective annual dividend rates and other relative rights and preferences of the respective series and classes, shall determine in good faith will result in fair and equitable treatment among the respective series or classes.
  (b)  
The Corporation shall not permit any subsidiary of the Corporation to purchase or otherwise acquire for consideration any shares of stock of the Corporation unless the Corporation could, under subparagraph (a) of this Section B (iv), purchase or otherwise acquire such shares at such time and in such manner.
  (v)  
Reacquired Shares. Any shares of Series C Junior Participating Preferred Stock purchased or otherwise acquired by the Corporation in any manner whatsoever shall be retired and cancelled promptly after the acquisition thereof. All such shares shall upon their cancellation become authorized but unissued shares of Preferred Stock and may be reissued as part of a new series of Preferred Stock to be created by resolution or resolutions of the Board of Directors, subject to the conditions and restrictions on issuance set forth herein.
 
  (vi)  
Liquidation, Dissolution or Winding Up.
  (a)  
Upon any liquidation (voluntary or otherwise), dissolution or winding up of the Corporation, no distribution shall be made to the holders of shares of stock ranking junior (either as to dividends or upon liquidation, dissolution or winding up) to the Series C Junior Participating Preferred Stock unless, prior thereto, the holders of shares of Series C Junior Participating Preferred Stock shall have received an amount equal to $1,000.00 per share of Series C Participating Preferred Stock, plus an amount equal to accrued and unpaid dividends and distributions thereon, whether or not declared, to the date of such payment (the “Series C Liquidation Preference”). Following the payment of the full amount of the Series C Liquidation Preference, no additional distributions shall be made to the holders of shares of Series C Junior Participating Preferred Stock unless, prior thereto, the holders of shares of Common Stock shall have received an amount per share (the “Common Adjustment”) equal to the quotient obtained by dividing (i)

 

8


 

     
the Series C Liquidation Preference by (ii) 10,000 (as appropriately adjusted as set forth in subparagraph (c) below to reflect such events as stock splits, stock dividends and recapitalizations with respect to the Common Stock) (such number in clause (ii), the “Adjustment Number”). Following the payment of the full amount of the Series C Liquidation Preference and the Common Adjustment in respect of all outstanding shares of Series C Junior Participating Preferred Stock and Common Stock, respectively, holders of Series C Junior Participating Preferred Stock and holders of shares of Common Stock shall receive their ratable and proportionate share of the remaining assets to be distributed in the ratio of the Adjustment Number to 1 with respect to such Preferred Stock and Common Stock, on a per share basis, respectively.
  (b)  
In the event, however, that there are not sufficient assets available to permit payment in full of the Series C Liquidation Preference and the liquidation preferences of all other series of preferred stock, if any, which rank on a parity with the Series C Junior Participating Preferred Stock, then such remaining assets shall be distributed ratably to the holders of such parity shares in proportion to their respective liquidation preferences. In the event, however, that there are not sufficient assets available to permit payment in full of the Common Adjustment, then such remaining assets shall be distributed ratably to the holders of Common Stock.
 
  (c)  
In the event the Corporation shall at any time after the Rights Declaration Date (i) declare any dividend on Common Stock payable in shares of Common Stock, (ii) subdivide the outstanding Common Stock, or (iii) combine the outstanding Common Stock into a smaller number of shares, then in each such case the Adjustment Number in effect immediately prior to such event shall be adjusted by multiplying such Adjustment Number by a fraction the numerator of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.
  (vii)  
Consolidation, Merger, etc. In case the Corporation shall enter into any consolidation, merger, combination or other transaction in which the shares of Common Stock are exchanged for or changed into other stock or securities, cash and/or any other property, then in any such case the shares of Series C Junior Participating Preferred Stock shall at the same time be similarly exchanged or changed in an amount per share (subject to the provision for adjustment hereinafter set forth) equal to 10,000 times the aggregate amount of stock, securities, cash and/or any other property (payable in kind), as the case may be, into which or for which each share of Common Stock is changed or exchanged. In the event the Corporation shall at any time after the Rights Declaration Date (i) declare any dividend on Common Stock payable in shares of Common Stock, (ii) subdivide the outstanding Common Stock, or (iii) combine the outstanding Common Stock into a smaller number of shares, then in each such case the amount set forth in the preceding sentence with respect to the exchange or change of shares of Series C Junior Participating Preferred Stock shall be adjusted by multiplying such amount by a fraction the numerator of

 

9


 

     
which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately prior to such event.
  (viii)  
No Redemption. The shares of Series C Junior Participating Preferred Stock shall not be redeemable.
 
  (ix)  
Ranking. The Series C Junior Participating Preferred Stock shall rank junior to all other series of the Corporation’s Preferred Stock as to the payment of dividends and the distribution of assets, unless the terms of any such series shall provide otherwise.
 
  (x)  
Amendment. At any time when any shares of Series C Junior Participating Preferred Stock are outstanding, neither the Certificate of Incorporation of the Corporation, as amended, nor this Certificate of Designation shall be amended in any manner which would materially alter or change the powers, preferences or special rights of the Series C Junior Participating Preferred Stock so as to affect them adversely without the affirmative vote of the holders of a majority or more of the outstanding shares of Series C Junior Participating Preferred Stock, voting separately as a class.
 
  (xi)  
Fractional Shares. Series C Junior Participating Preferred Stock may be issued in fractions of a share which shall entitle the holder, in proportion to such holder’s fractional shares, to exercise voting rights, receive dividends, participate in distributions and to have the benefit of all other rights of holders of Series C Junior Participating Preferred Stock.
  C.  
Common Stock . The Common Stock shall have the following powers, preferences, rights, qualifications, limitations and restrictions:
  (i)  
After the requirements with respect to preferential dividends of Preferred Stock, if any, shall have been met and after this Corporation shall comply with all the requirements, if any, with respect to the setting aside of funds as sinking funds or redemption or purchase accounts, and subject further to any other conditions that may be required by the Delaware General Corporation Law, then but not otherwise, the holders of Common Stock shall be entitled to receive such dividends, if any, as may be declared from time to time by the board of directors without distinction to series;
 
  (ii)  
After distribution in full of any preferential amount to be distributed to the holders of Preferred Stock, if any, in the event of a voluntary or involuntary liquidation, distribution or sale of assets, dissolution or winding up of this Corporation, the holders of the Common Stock shall be entitled to receive all of the remaining assets of the Corporation, tangible and intangible, or whatever kind available for distribution to stockholders, ratably in proportion to the number of shares of Common Stock held by each without distinction as to series; and
 
  (iii)  
Except as may otherwise be required by law or this Certificate of Incorporation, in all matters as to which the vote or consent of stockholders of the Corporation shall be required or be taken, including, any vote to amend this Certificate of Incorporation, to increase or decrease the par value of any class of stock, effect a stock split or

 

10


 

     
combination of shares, or alter or change the powers, preferences or special rights of any class or series of stock, the holders of the Common Stock shall have one vote per share of Common Stock on all such matters and shall not have the right to cumulate their votes for any purpose.
  D.  
Other Provisions .
  (i)  
The board of directors of the Corporation shall have authority to authorize the issuance, from time to time without any vote or other action by the shareholders, of any or all shares of the Corporation of any class at any time authorized, and any securities convertible into or exchangeable for such shares, in each case to such persons and for such consideration and on such terms as board of directors from time to time in its discretion lawfully may determine; provided, however, that the consideration for the issuance of shares of stock of the Corporation having par value shall not be less than such par value. Shares so issued, for which the full consideration determined by the board of directors has been paid to the Corporation, shall be fully paid stock, and the holders of such stock shall not be liable for any further call or assessment thereon.
 
  (ii)  
Unless otherwise provided in the resolution of the board of directors providing for the issue of any series of Preferred Stock, no holder of shares of any class of the corporation or of any security of obligation convertible into, or of any warrant, option or right to purchase, subscribe for or otherwise acquire, shares of any class of the Corporation, whether now or hereafter authorized, shall, as such holder, have any preemptive right whatsoever to purchase, subscribe for or otherwise acquire shares of any class of the Corporation, whether now or hereafter authorized.
 
  (iii)  
Anything herein contained to the contrary notwithstanding, any and all right, title, interest and claim in and to any dividends declared or other distributions made by the Corporation, whether in cash, stock or otherwise, that are unclaimed by the stockholder entitled thereto for a period of six years after the close of business on the payment date, shall be and be deemed to be extinguished and abandoned; and such unclaimed dividends or other distributions in the possession of the Corporation, its transfer agents or other agents or depositories shall at such time becomes the absolute property of the Corporation, free and clear of any and all claims of any person whatsoever.
Article V
Limitation on Liability
A director of the Corporation shall have no personal liability to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except (i) for any breach of a director’s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) under section 174 of the General Corporation Law of Delaware as it may from time to time be amended or any successor provision thereto, or (iv) for any transaction from which a director derived an improper personal benefit.

 

11


 

Article VI
Business Combinations with Interested Stockholders
The Corporation elects not to be governed by the provisions of section 203 of the General Corporation Law of Delaware regarding business combinations with interested shareholders.
Article VII
Registered Office and Registered Agent
The name and address of the Corporation’s registered agent in the state of Delaware is The Corporation Trust Company, 1209 Orange Street, in the city of Wilmington, county of New Castle, Delaware. Either the registered office or the registered agent may be changed in the manner provided by law.
Article VIII
Amendment
The Corporation reserves the right to amend, alter, change, or repeal all or any portion of the provisions contained in its Certification of Incorporation from time to time in accordance with the laws of the State of Delaware, and all rights conferred on stockholders herein are granted subject to this reservation.
Article IX
Adoption and Amendment of Bylaws
The initial bylaws of the Corporation shall be adopted by the board of directors. The power to alter, amend, or repeal the bylaws or adopt new bylaws shall be vested in the board of directors, but the stockholders of the Corporation may also alter, amend, or repeal the bylaws or adopt new bylaws. The bylaws may contain any provisions for the regulation or management of the affairs of the Corporation not inconsistent with the laws of the state of Delaware now or hereafter existing.
Article X
Directors
The number of directors of the Corporation shall be set forth in the bylaws of the Corporation, which number may be increased or decreased pursuant to the bylaws of the Corporation. The board of directors is authorized to make, alter or repeal the bylaws of the Corporation. The board of directors shall be classified, in respect solely to the time for which they shall severally hold office, by dividing them into three (3) classes, each such class to be as nearly as possible equal in number of directors to each other class. The first term of office of directors of the first class shall expire at the first annual meeting after their election, and thereafter such terms shall expire on each three (3) year anniversary of such date; the term of office of the directors of the second class shall expire on the one (1) year anniversary of the first annual meeting after their election, and thereafter such terms shall expire on each three (3) year anniversary of such one (1) year anniversary; and the term of office of the directors of the third class shall expire on the two (2) year anniversary of the first annual meeting after their election, and thereafter such terms shall expire on each three (3) year anniversary of such two (2) year

 

12


 

anniversary. At each succeeding annual meeting, the stockholders shall elect directors for a full term or the remainder thereof, as the case may be, to succeed those whose terms have expired. Each director shall hold office for the term for which elected and until his successor shall be elected and qualify.

 

13


 

IN WITNESS WHEREOF, I have executed and attested this Amended and Restated Certificate of Incorporation this 1 st day of September, 2009 in accordance with Section 303 of the Delaware General Corporation Law.
         
     
By:        
  Declan Daly, Chief Executive Officer     
       

 

14

Exhibit 3.2
FOURTH AMENDED AND RESTATED BYLAWS
OF
FIBROCELL SCIENCE, INC.
ARTICLE I—OFFICES
Section 1.01 Registered Office. The registered office shall be in the city of Wilmington, county of New Castle, state of Delaware.
Section 1.02 Locations of Offices. The corporation may also have offices at such other places both within and without the state of Delaware as the board of directors may from time to time determine or the business of the corporation may require.
ARTICLE II—STOCKHOLDERS
Section 2.01 Annual Meeting. The annual meeting of the stockholders shall be held on such date and at such time as is designated by the board of directors and as is provided for in the notice of the meeting. If the election of directors shall not be held on the day designated herein for the annual meeting of the stockholders, or at any adjournment thereof, the board of directors shall cause the election to be held at a special meeting of the stockholders as soon thereafter as may be convenient.
Section 2.02 Special Meetings. Special meetings of the stockholders may be called at any time by the chairman of the board, the chief executive officer, the president, or by the board of directors, or in their absence or disability, by any vice president.
Section 2.03 Place of Meetings. The board of directors may designate any place, either within or without the state of incorporation, as the place of meeting for any annual meeting or for any special meeting called by the board of directors. A waiver of notice signed by all stockholders entitled to vote at a meeting may designate any place, either within or without state of incorporation, as the place for the holding of such meeting. If no designation is made, or if a special meeting be otherwise called, the place of meeting shall be at the principal office of the corporation.
Section 2.04 Notice of Meetings. The secretary or assistant secretary, if any, shall cause notice of the time, place, and purpose or purposes of all meetings of the stockholders (whether annual or special), to be mailed at least ten (10) but not more than sixty (60) days prior to the meeting, to each stockholder of record entitled to vote.
Section 2.05 Waiver of Notice. Any stockholder may waive notice of any meeting of stockholders (however called or noticed, whether or not called or noticed and whether before, during, or after the meeting), signing a written waiver of notice or a consent to the holding of such meeting, or an approval of the minutes thereof. Attendance at a meeting, in person or by proxy, shall constitute waiver of all defects of notice regardless of whether waiver consent, or approval is signed or any objections are made, unless attendance is solely for the purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. All such waivers, consents, or approvals shall be made a part of the minutes of the meeting.
Section 2.06 Fixing Record Date. For the purpose of determining stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, or to express consent to corporate action in writing without a meeting, or stockholders entitled to receive payment of any dividend or other distribution or allotment of any rights or entitled to exercise any rights in respect to any change, conversion, or exchange of stock, or for the purpose of any other lawful action, the board of directors may fix in advance a date as the record date for any such determination of stockholders, such date in any case to be not more than sixty (60) days and, in case, of a meeting of stockholders, not less than ten (10) days prior to the date on which the particular action requiring such determination of stockholders is to be taken. If no record date is fixed for the determination of stockholders entitled to notice of or to vote at a meeting, the day preceding the date on which notice of the meeting is mailed shall be the record date. For any other purpose, the record date shall be the close of business on the date on which the resolution of the board

 

 


 

of directors pertaining thereto is adopted. When a determination of stockholders entitled to vote at any meeting of stockholders has been made as provided in this section, such determination shall apply to any adjournment thereof. Failure to comply with this section shall not affect the validity of any action taken at a meeting of stockholders.
Section 2.07 Voting Lists. The officers of the corporation shall cause to be prepared from the stock ledger at least ten days before every meeting of stockholders, a complete list of the stockholders entitled to vote at such meeting or any adjournment thereof, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, during ordinary business hours, for a period of at least ten days prior to the meeting, either at a place within the city where the meeting is to be held, which place shall be specified in the notice of the meeting, or, if not so specified, at the place where the meeting is to be held. The list shall also be produced and kept at the time and place of the meeting, during the whole time thereof, and may be inspected by any stockholder who is present. The original stock ledger shall be the only evidence as to who are the stockholders entitled to examine the stock ledger, the list required by this section, or the books of the corporation, or to vote in person or by proxy at any meeting of stockholders.
Section 2.08 Quorum. A majority of the stock issued and outstanding and entitled to vote, present in person or represented by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business, except as otherwise provided by statute or by the certificate of incorporation. If, however, such quorum shall not be present or represented at any meeting of the stockholders, the stockholders, entitled to vote thereat, present in person or represented by proxy, shall have power to adjourn the meeting from time to time without notice other than so announcement at the meeting, until a quorum shall be present represented. At such adjourned meeting at which a quorum shall be present or represented any business may be transacted which might have been transacted at the meeting as originally notified. If the adjournment is for more than thirty (30) days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.
Section 2.09 Vote Required. When a quorum is present at any meeting, the vote of the holders of stock having a majority of the voting power present in person or represented by proxy shall decide any question brought before such meeting, unless the question is one on which by express provision of the statutes of the state of Delaware or of the certificate of incorporation a different vote is required, in which case such express provision shall govern and control the decision of such question.
Section 2.10 Voting of Stock. Unless otherwise provided in the certificate of incorporation, each stockholder shall at every meeting of the stockholders be entitled to one vote in person or by proxy for each share of the capital stock having voting power held by such stockholder, subject to the modification of such voting rights of any class or classes of the corporation’s capital stock by the certificate of incorporation.
Section 2.11 Proxies. At each meeting of the stockholders, each stockholder entitled to vote shall be entitled to vote in person or by proxy, provided however, that the right to vote by proxy shall exist only in case the instrument authorizing such proxy to act shall have been executed in writing by the registered holder or holders of such stock, as the case may be, as shown on the stock ledger of the corporation or by his attorney thereunto duly authorized in writing. Such instrument authorizing a proxy to act shall be delivered at the beginning of such meeting to the secretary of the corporation or to such other officer or person who may, in the absence of the secretary, be acting as secretary of the meeting. In the event that any such instrument shall designate two or more persons to act as proxy, a majority of such persons present at the meeting, or if only one be present, that one shall (unless the instrument shall otherwise provide) have all of the powers confirmed by the instrument on all persons so designated. Persons holding stock in a fiduciary capacity, shall be entitled to vote the stock so held and the persons whose shares are pledged shall be entitled to vote, unless, the transfer by the pledgor in the books and records of the corporation shall have expressly empowered the pledgee to vote thereon, in which case the pledgee, or his proxy, may represent such stock and vote thereon. No proxy shall be voted or acted on after three years from its date, unless the proxy provides for a longer period.
Section 2.12 No Stockholder Action by Written Consent Without a Meeting. Any action required to be taken at any annual or special meeting of stockholders of the corporation, or any action that may be taken at any annual or

 

2


 

special meeting of such stockholders, must be taken at an annual or special meeting of stockholders of the corporation, with prior notice and with a vote, and may not be taken by a consent in writing.
Section 2.13 Business at Annual Meeting. At any annual meeting of the shareholders, only such business shall be conducted as shall have been brought before the meeting (a) by or at the direction of the board of directors or (b) by any shareholder of record of the corporation who is entitled to vote with respect thereto and who complies with the notice procedures set forth in this section. For business to be properly brought before an annual meeting by a shareholder, the shareholder must have given timely notice thereof in writing to the secretary of the corporation. To be timely, a shareholders notice shall be received at the principal executive offices of the corporation not less than 120 calendar days in advance of the date in the current fiscal year that corresponds to the date in the preceding fiscal year on which the corporation’s notice of meeting and related proxy or information statement were released to shareholders in connection with the previous years annual meeting of shareholders, except that if no meeting was held in the immediately preceding year or if the date of the annual meeting in the current fiscal year has been changed by more than 30 calendar days’ from the corresponding date of such meeting in the preceding fiscal year, such notice by the shareholder proposing business to be brought before the shareholders’ meeting must be received not less than 30 days prior to the date of the current year’s annual meeting; provided, that in the event that less than 40 days notice of the date of the meeting is given to shareholders, to be timely, a shareholders notice of business to be brought before the meeting shall be so received not later than the close of business on the 10th day following the day on which such notice of the date of the annual meeting was mailed. A shareholders notice to the secretary shall set forth as to each matter such shareholder proposes to bring before the annual meeting (a) a brief description of the business desired to be brought before the annual meeting and the reasons for conducting such business at the annual meeting. (b) the name and address, as they appear on the corporation’s books, of the shareholder of record proposing such business, (c) the class and number of shares of the corporation’s capital stock that are beneficially owned by such shareholder, and (d) any material interest of such shareholder in such business. Notwithstanding anything in these bylaws to the contrary, no business shall be brought before or conducted at an annual meeting except in accordance with the provisions of this section. The officer of the corporation or the person presiding at the annual meeting shall, if the facts so warrant, determine and declare to the meeting that business was not properly brought before the meeting in accordance with such provisions, and if such presiding officer should so determine and declare to the meeting that business was not properly brought before the meeting in accordance with such provisions and if such presiding officer should so determine, such presiding officer shall so declare to the meeting, and any such business so determined to be not properly brought before the meeting shall not be transacted.
Section 2.14 Notification of Nominations. Nominations for the election of directors may be made by the board of directors or by any shareholder entitled to vote for the election of directors and who complies with the notice procedures set forth in this section. Any shareholder entitled to vote for the election of directors at a meeting may nominate persons for election as directors only if written notice of such shareholder’s intention to make such nomination is delivered or mailed to and received at the principal executive offices of the corporation not later than 120 calendar days in advance of the date in the current fiscal year that corresponds to the date in the preceding fiscal year on which the corporation’s notice of meeting and related proxy, or information statement were released to shareholders in connection with the previous years annual meeting of shareholders, except that (i) with respect to an election to be held at an annual meeting of shareholders, if no annual meeting was held in the immediately preceding year or if the date of the annual meeting in the current fiscal year has been changed by more than 30 calendar days’ from the corresponding date of such meeting in the preceding fiscal year, such notice by the shareholder must be received not less than 30 days prior to the date of the current year’s annual meeting; provided, that in the event that less than 40 days notice of the date of the meeting is given or made to shareholders, to be timely, a shareholders notice shall be so received not later than the close of business on the 10th day, following the day on which such notice of the date of the annual meeting was mailed, and (ii) with respect to an election to be hold at a special meeting of shareholders for the election of directors, the close of business on the seventh day following the date on which notice of such meeting is first given to shareholders. Each such notice shall set forth:
(a) the name and address of the shareholder who intends to make the nomination and of the person or persons to be nominated;

 

3


 

(b) a representation that such shareholder is a holder of record of stock of the corporation entitled to vote at such meeting, and intend to appear in person or by proxy at the meeting to nominate the person or person specified in the notice;
(c) a description of all arrangements or understandings between such shareholder and each nominee, and any other person or persons (naming such person or persons) pursuant to which the nomination or nominations are to be made by such shareholder;
(d) such other information regarding each nominee proposed by such shareholder as would have been required to be included in a proxy statement filed pursuant to the proxy rules of the Securities and Exchange Commission had each nominee been nominated, or intended to be nominated by the board of directors; and
(e) the consent of each nominee to serve as a director of the corporation if elected.
The chairman of a shareholder meeting may refuse to acknowledge the nomination of any person not made in compliance with the foregoing procedure.
ARTICLE III—DIRECTORS
Section 3.01 Number, Term, and Qualifications. The number of directors which shall constitute the whole board shall be not less than three nor more than eleven. No reduction of the authorized number of directors shall have the effect of removing any director before that director’s term of office expires. The board of directors shall be divided into three classes, as nearly equal in number as possible. Directors shall be assigned to each class in accordance with a resolution or resolutions adopted by the board of directors. The term of office of the first class (Class I) shall expire at the first annual meeting of stockholders or any special meeting in lieu thereof following their election, the term of office of the second class (Class II) shall expire at the second annual meeting of stockholders or any special meeting in lieu thereof following their election and the term of office of the third class (Class III) shall expire at the third annual meeting of stockholders or any special meeting in lieu thereof following their election. At each annual meeting of stockholders or special meeting in lieu thereof, directors elected to succeed those directors whose terms expire shall be elected for a term of office to expire at the third succeeding annual meeting of the stockholders or special meeting in lieu thereof after their election and until their successors are duly elected and qualified. Directors need not be residents of the state of incorporation or stockholders of the corporation.
Section 3.02 Vacancies and Newly Created Directorships. Vacancies resulting from any increase in the authorized number of directors or any vacancies in the board of directors resulting from death, resignation, retirement, disqualification, removal from office or other cause may be filled only by a majority vote of the directors then in office even though less than a quorum, or by a sole remaining director, and not by the stockholders. In the event of any increase or decrease in the authorized number of directors, (a) each director then serving as such shall nevertheless continue as a director of the class of which he or she is a member until the expiration of his or her current term or his or her prior death, retirement, removal or resignation and (b) the newly created or eliminated directorships resulting from such increase or decrease shall if reasonably possible be apportioned by the board of directors among the three classes of directors so as to ensure that no one class has more than one director more than any other class. In the event of a vacancy in the board of directors, the remaining directors, except as otherwise provided by law, may exercise the powers of the full board of directors until the vacancy is filled. Notwithstanding the foregoing, each director shall serve until his or her successor is duly elected and qualified or until his or her death, resignation or removal. If there are no directors in office, then an election of directors may be hold in the manner provided by statute.
Section 3.03 General Powers. The business of the corporation shall be managed under the direction of its board of directors which may exercise all such powers of the corporation and do all such lawful acts and things as are not by statute or by the certificate of incorporation or by these bylaws directed or required to be exercised or done by the stockholders.

 

4


 

Section 3.04 Regular Meetings. A regular meeting of board of directors shall be held without other notice than this bylaw immediately following and at the same place as the annual meeting of stockholders. The board of directors may provide by resolution, the time and place, either within or without the state of incorporation, for the holding of additional regular meetings without other notice than such resolution.
Section 3.05 Special Meetings. Special meetings of the board of directors may be called by or at the request of the chairman of the board, the chief executive officer, the president, or any two directors. The person or persons authorized to call special meetings of the board of directors may fix any place, either within or without the state of incorporation, as the place for holding any special meeting of the board of directors called by them.
Section 3.06 Meetings by Telephone Conference Call. Members of the board of directors may participate in a meeting of the board of directors or a committee of the board of directors by means of conference telephone or similar communication equipment by means of which all persons participating in the meeting can hear each other, and participation in a meeting pursuant to this section shall constitute presence in person at such meeting.
Section 3.07 Notice. Notice of any special meeting shall be delivered personally or by telephone to each director or sent by first-class mail or telegram, charges prepaid, addressed to each director at that director’s address as it is shown on the records of the corporation. If the notice is mailed, it shall be deposited in the United States mail at least four (4) days before the time of the holding of the meeting. If the notice is delivered personally or by telephone or by telegram, it shall be delivered personally or by telephone or to the telegraph company at least twenty-four (24) hours before the time of the holding of the meeting Any director may waive notice of any meeting. Attendance of a director at a meeting shall constitute a waiver of notice of such meeting, except where a director attends a meeting solely for the express purpose of objecting to the transaction of any business because the meeting is not lawfully called or convened.
Section 3.08 Quorum. A majority of the number of directors shall constitute a quorum for the transaction of business at any meeting of the board of directors, but if less than a majority is present at a meeting, a majority of the directors present may adjourn the meeting from time to time without further notice.
Section 3.09 Manner of Acting. The act of a majority of the directors present at a meeting at which a quorum is present shall be the act of the board of directors, and individual directors shall have no power as such.
Section 3.10 Compensation. Unless otherwise restricted by the certificate of incorporation or these bylaws, the board of directors shall have the authority to fix the compensation of directors. No such compensation shall preclude any director from serving the corporation in any other capacity and receiving compensation therefor.
Section 3.11 Presumption of Assent. A director of the corporation who is present at a meeting of the board of directors at which action on any corporate matter is taken shall be presumed to have assented to the action taken unless his dissent shall be entered in the minutes of the meeting, unless he shall file his written dissent to such action with the person acting as the secretary of the meeting before the adjournment thereof, or shall forward such dissent by registered or certified mail to the secretary of the corporation immediately after the adjournment of the meeting. Such right to dissent shall not apply to a director who voted in favor of such action.
Section 3.12 Resignations. A director may resign at any time by delivering a written resignation to either the president, a vice president, the secretary or assistant secretary, if any. The resignation shall become effective on its acceptance by the board of directors provided, that if the board has not acted thereon within ten days from the date presented, the resignation shall be deemed accepted.
Section 3.13 Written Consent to Action by Directors. Any action required to be taken at a meeting of the directors of the corporation or any other action which may be taken at a meeting of the directors or of a committee, may be taken without a meeting, if a consent in writing, setting forth the action so taken, shall be signed by all of the directors, or all of the members of the committee, as the case may be. Such consent shall have the same legal effect as a unanimous vote of all the directors or members of the committee.

 

5


 

Section 3.14 Removal. At a meeting expressly called for that purpose, one or more directors may be removed for cause by a vote of a majority of the shares of outstanding stock of the corporation entitled to vote at an election of directors.
ARTICLE IV—OFFICERS
Section 4.01 Number. The officers of the corporation shall be a president, one or more vice presidents, as shall be determined by resolution of the board of directors, a secretary, a treasurer, and such other officers as may be appointed by the board of directors. The board of directors may elect but shall not be required to elect a chairman of the board, who may or may not also be an officer of the corporation, and the board of directors may appoint a general manager.
Section 4.02 Election Term of Office, and Qualifications. The officers shall be chosen by the board of directors annually at its annual meeting. In the event of failure to choose officers at an annual meeting of the board of directors, officers may be chosen at any regular or special meeting of the board of directors. Each such officer (whether chosen at an annual meeting of the board of directors to fill a vacancy or otherwise) shall hold his office until the next ensuing annual meeting of the board of directors and until his successor shall have been chosen and qualified, or until his death or until his resignation or removal in the manner provided in these bylaws. Any one person may hold any two or more of such offices, except that the president shall not also be the secretary. No person holding two or more offices shall act in or execute any instrument in the capacity of more than one office.
Section 4.03 Subordinate Officers, Etc. The board of directors from time to time may appoint such other officers or agents as it may, deem advisable, each of whom shall have such title, hold office for such period, have such authority, and perform such duties as the board of directors from time to time may determine. The board of directors from time to time may, delegate to any officer or agent the power to appoint any such subordinate officer or agents and to prescribe their respective titles, terms of office, authorities, and duties. Subordinate officers need not be stockholders or directors.
Section 4.04 Resignations. Any officer may resign at any time by delivering a written resignation to the board of directors, the president, or the secretary. Unless otherwise specified therein, such resignation shall take effect on delivery.
Section 4.05 Removal. Any officer may be removed from office at any special meeting of the board of directors called for that purpose or at a regular meeting, by the vote of a majority of the directors, with or without cause. Any officer or agent appointed in accordance with the provisions of section 4.03 hereof may also be removed, either with or with cause, by any officer on whom such power of removal shall have been conferred by the board of directors.
Section 4.06 Vacancies and Newly Created Offices. If any vacancy shall occur in any office by reason of death, resignation, removal, disqualification, or any other cause, or if a new office shall be created, then such vacancies or newly created officers may be filled by the board of directors at any regular or special meeting.
Section 4.07 Chairman of the Board. The chairman of the board, who may or may not also be an officer of the corporation, shall have the following powers and duties:
(a) He shall preside at all stockholders meetings;
(b) He shall preside at all meetings of the board, of directors; and
(c) He shall be a member of the executive committee, if any.
Section 4.08 The President. The president shall have the following powers and duties:

 

6


 

(a) If no general manager has been appointed he shall be the chief executive officer of the corporation and, subject to the direction of the board of directors, shall have general charge of the business, affairs, and property of the corporation and general supervision over its officers, employees, and agents;
(b) If no chairman of the board has been chosen, or if the chairman of the board is absent or disabled, he shall preside at meetings of the stockholders and board of directors;
(c) He shall be a member of the executive committee, if any,
(d) He shall be empowered to sign certificates representing stock of the corporation, the issuance of which shall have been authorized by the board of directors; and
(e) He shall have all power and perform all duties normally incident to the office of a president of a corporation and shall exercise such other powers and perform such other duties as from time to time may be assigned to him by the board of directors.
Section 4.09 The Vice Presidents. The board of directors may, from time to time, designate and elect one or more vice presidents, one of whom may be designated to serve as executive vice president. Each vice president shall have such powers and perform such duties as from time to time may be assigned to him by the board of directors or the president. At the request or in the absence or disability of the president, the executive vice president or, in the absence or disability of the executive vice president, the vice president designated by the board of directors or (in the absence of such designation by the board of directors) by the president as senior vice president may perform all the duties of the president, and when so acting, shall have all the powers of, and be subject to all the restrictions on, the president.
Section 4.10 The Secretary. The secretary shall have the following powers and duties:
(a) He shall keep or cause to be kept a record of all of the proceedings of the meetings of the stockholders and of the board of directors, in books provided for that purpose;
(b) He shall cause all notices to be duly given in accordance with the provisions of these bylaws and as required by statute;
(c) He shall be the custodian of the records and of the seal of the corporation, and shall cause such seal (or a facsimile thereof) to be affixed to all certificates representing stock of the corporation prior to the issuance thereof and to all instruments, the execution of which on behalf of the corporation under its seal shall have been duly authorized in accordance with these bylaws, and when so affixed, he may attest the same;
(d) He shall see that the books, reports, statements, certificates, and other documents and records required by statute are properly kept and filed;
(e) He shall have charge of the stock ledger and books of the corporation and cause such books to be kept in such manner as to show at any time the amount of the stock of the corporation of each class issued and outstanding, the manner in which and the time when such stock was paid for, the names alphabetically arranged and the addresses of the holders of record thereof, the amount of stock held by each holder and time when each became such holder of record; and he shall exhibit at all reasonable times to any director, on application, the original or duplicate stock ledger. He shall cause the, stock ledger referred to in Section 6.04 hereof to be kept and exhibited at the principal office of the corporation, or at such other place as the board of directors shall determine, in the manner and for the purpose provided in such section;
(f) He shall be empowered to, sign certificates representing stock of the corporation, the issuance of which shall have been authorized by the board of directors; and

 

7


 

(g) He shall perform in general all duties incident to the office of secretary and such other duties as are given to him by these bylaws or as from time to time may be assigned to him by the board of directors or the president.
Section 4.11 The Treasurer. The treasurer shall have the following powers and duties:
(a) He shall have charge and supervision over and be responsible for the monies, securities, receipts, and disbursements of the corporation;
(b) He shall cause the monies and other valuable effects. of the corporation to be deposited in the name and to the credit of the corporation in such banks or trust companies or with such banks or other depositories as shall be selected in accordance with section 5.03 hereof,
(c) He shall cause the monies of the corporation to be disbursed by checks or drafts (signed as provided in section 5.04 hereof) drawn on the authorized depositories of the corporation, and cause to be taken and preserved properly vouchers for all monies disbursed;
(d) He shall render to the board of directors or the president, whenever requested, a statement of the financial condition of the corporation and of all of his transactions as treasurer, and render a full financial report at the annual meeting of the stockholders, if called on to do so;
(e) He shall cause to be kept correct books of account of all the business and transactions of the corporation and exhibit such books to any directors on request during business hours;
(f) He shall be empowered from time to time to require from all officers or agents of the corporation reports or statements giving such information as he may desire with respect to any and all financial transactions of the corporation; and
(g) He shall perform in general all duties incident to the office of treasurer and such other duties as are given to him by these bylaws or as from time to time may be assigned to him by the board of directors or the president.
Section 4.12 General Manager. The board of directors may employ and appoint a general manager who may, or may not be one of the officers or directors of the corporation. The general manager, if any, shall have the following powers and duties:
(a) He shall be the chief executive officer of the corporation and, subject to the directions of the board of directors, shall have, general charge of the business affairs and property of the corporation and general supervision over its officers, employees, and agents;
(b) He shall have the exclusive management of the business of the corporation and of all of its dealings, but at all times subject to the control of thee board of directors;
(c) Subject to the approval of the board of directors or the executive committee, if any, he shall employ all employees of: the corporation or delegate such employment to subordinate officers, or such division chiefs, and shall have authority to discharge any person so employed; and
(d) He shall make a report to the president and directors quarterly, or more often if required to do so, setting forth the result of, the operations under his charge, together with suggestions looking to the improvement and betterment of the condition of the corporation, and shall perform such other duties as the board of directors shall require.

 

8


 

Section 4.13 Salaries. The salaries or other compensation of the officers of the corporation shall be fixed from time to time by the board of directors, except that the board of directors may delegate to any person or group of persons the power to fix the salaries or other compensation of any subordinate officers or agents appointed in accordance with the provisions of section 4.03 hereof. No officer shall be prevented from receiving any such salary or compensation by reason of the fact that he is also a director of the corporation.
Section 4.14 Surety Bonds. In case the board, of directors shall so require, any officer or agent of the corporation shall execute to the corporation a bond in such sums and with such surety or sureties as the board of directors may direct, conditioned on the faithful performance of his duties to the corporation, including responsibility for negligence and for the accounting of all property, monies, or securities of the corporation which may come into his hands.
ARTICLE V—EXECUTION OF INSTRUMENTS,
BORROWING OF MONEY, AND DEPOSIT OF CORPORATE FUNDS
Section 5.01 Execution of Instruments. Subject to any limitation contained in the certificate of incorporation or these bylaws, the president or any vice president or the general manager, if any, may, in the name and on behalf of the corporation, execute and deliver any contract or other instrument authorized in writing by the board of directors. The board of directors may, subject to any limitation contained in the certificate of incorporation or in these bylaws, authorize in writing any officer or agent to execute and deliver any contract or other instrument in the name and on behalf of the corporation; any such authorization may be general or confined to specific instances.
Section 5.02 Loans. No loan or advance shall be contracted on behalf of the corporation, no negotiable paper or other evidence of its obligation under any loan or advance shall be issued in its name, and no property of the corporation shall be mortgaged, pledged, hypothecated, transferred, or conveyed as security for the payment of any loan, advance, indebtedness, or liability of the corporation, unless and except as authorized by the board of directors. Any such authorization may be general or confined to specific instances.
Section 5.03 Deposits. All monies of the corporation not otherwise employed shall be deposited from time to time to its credit in such banks or trust companies or with such bankers or other depositories as the board of directors may select, or as from time to time may be selected by any officer or agent authorized to do so by the board of directors.
Section 5.04 Checks, Drafts. Etc. All notes, drafts, acceptances, checks, endorsements, and, subject to the provisions of these bylaws, evidences of indebtedness of the corporation shall be signed by such officer or officers or such agent or agents of the corporation and in such manner as the board of directors from time to time may determine. Endorsements for deposit to the credit of the corporation in any of its duly authorized depositories shall be in such manner as the board of directors from time to time may determine.
Section 5.05 Bonds and Debentures. Every bond or debenture issued by the corporation shall be evidenced by an appropriate instrument which shall be signed by the president or a vice president and by the secretary and sealed with the seal of the corporation. The seal may be a facsimile, engraved or printed. Where such bond or debenture is authenticated with the manual signature of an authorized officer of the corporation or other trustee designated by the indenture of trust or other agreement under which such security is issued, the signature of any of the corporation’s officers named thereon may be a facsimile. In case any officer who signed, or whose facsimile signature has been used on any such bond or debenture, shall cease to be an officer of the corporation for any reason before the same has been delivered by the corporation, such bond or debenture may nevertheless be adopted by the corporation and issued and delivered as through the person who signed it or whose facsimile signature has been used thereon had not ceased to be such officer.
Section 5.06 Sale, Transfer, Etc. of Securities. Sales, transfers, endorsements, and assignments of stocks, bonds, and other securities owned by or standing the name of the corporation, and the execution and delivery on behalf of the corporation of any all instruments in writing incident to any such sale, transfer, endorsement, or

 

9


 

assignment, shall be effected by the president, or by any vice president, together with the secretary, or by any officer or agent thereunto authorized by the board of directors.
Section 5.07 Proxies. Proxies to vote with respect to stock of other corporations owned by or standing in the name of the corporation shall be executed and delivered on behalf of the corporation by the president or any vice president and the secretary or assistant secretary of the corporation, or by any officer or agent thereunder authorized by the board of directors.
ARTICLE VI—CAPITAL STOCK
Section 6.01 Stock Certificates; Uncertificated Securities. Every holder of stock in the corporation shall be entitled to have a certificate, signed by the president or any vice president the secretary or assistant secretary, and sealed with the seal (which may be a facsimile, engraved, or printed) of the corporation, certifying the number and kind, class or series of stock owned by him in the corporation; provided, however , that where such a certificate is countersigned by (a) a transfer agent or an assistant transfer agent, or (b) registered by a registrar, the signature of any such president, vice president, secretary, or assistant secretary may be a facsimile. Notwithstanding the foregoing, the board of directors may provide by resolution or resolutions that some or all of any or all classes or series of the corporation’s securities shall be uncertificated securities. Any such resolution shall not apply to securities represented by a certificate until such certificate is surrendered to the corporation. Notwithstanding the adoption of such a resolution by the board of directors, every holder of stock represented by certificates, and upon request, every holder of uncertificated securities shall be entitled to have a certificate, signed by, or in the name of the corporation by the chairman or vice-chairman, or the president or vice-president, and by the treasurer or an assistant treasurer, or the secretary or assistant secretary of the corporation, representing the number of securities registered in certificate form. In case any officer who shall have signed, or whose facsimile signature or signatures shall have been used on any such certificate, shall cease to be such officer of the corporation, for any reason, before the delivery of such certificate by the corporation, such certificate may nevertheless be adopted by the corporation and be issued and delivered as though the person who signed it, or whose facsimile signature or signatures shall have been used thereon, has not ceased to be such officer. Certificates representing stock of the corporation shall be in such form as provided by the statutes of the state of incorporation. There shall be entered on the stock books of the corporation at the time of issuance of each share, the number of the certificate issued if in certificate form, the name and address of the person owning the stock represented thereby, the number and kind, class or series of such stock, and the date of issuance thereof. Every certificate exchanged or returned to the corporation shall be marked “canceled” with the date of cancellation.
Section 6.02 Transfer of Stock. Transfers of stock of the corporation shall be made on the books of the corporation by the holder of record thereof, or by his attorney thereunto duly authorized by a power of attorney duly executed in writing and filed by the secretary of the corporation or any of its transfer agents, and on surrender of the certificate or certificates, if in certificate form, properly endorsed or accompanied by proper instruments of transfer, representing such stock. Except as provided by law, the corporation and transfer agents and registrars, if any, shall be entitled to treat the holder of record of any stock as the absolute owner thereof for all purposes, and accordingly shall not be bound to recognize any legal, equitable, or other claim to or interest in such stock on the part of any other person whether or not it or they shall have express or other notice thereof.
Section 6.03 Regulations. Subject to the provisions of articles IV and V of the certificate of incorporation, the board of directors may make such rules and regulations as they may deem expedient concerning the issuance, transfer, redemption, and registration of certificates or uncertificated securities for stock of the corporation.
Section 6.04 Maintenance of Stock Ledger at Principal Place of Business. A stock ledger (or ledgers where more than one kind, class, or series of stock is outstanding) shall be kept at the principal place of business of the corporation, or at such other place the board of directors shall determine, containing the names alphabetically arranged of original holders of the corporation, their addresses, their interest, the amount paid on their securities, and all transfers thereof and the number and class of stock held by each. Such stock ledgers shall at all reasonable hours by subject to inspection by persons entitled by law to inspect the same.

 

10


 

Section 6.05 Transfer Agents and Registrars. The board of directors may appoint one or more transfer agents and one or more registrars with respect to the certificates or uncertificated securities representing stock of the corporation, and may require all such certificates to bear the signature of either or both. The board of directors may from time to time define the respective duties of such transfer agents and registrars. No certificate for stock shall be valid until countersigned by a transfer agent, if at the date appearing thereon the corporation had a transfer agent for such stock, and until registered by a registrar, if at such date the corporation had a registrar for such stock.
Section 6.06 Closing of Transfer Books and Fixing of Record Date.
(a) The board of directors shall have power to close the stock ledgers of the corporation for a period of not to exceed sixty (60) days preceding the date of any meeting of stockholders, or the date for payment of any dividend, or the date for the allotment of rights, or capital stock shall go into effect, or a date in connection with obtaining the consent of stockholders for any purpose.
(b) In lieu of closing the stock ledgers as aforesaid, the board of directors may fix in advance a date not exceeding sixty (60) days preceding the date of any meeting of stockholders, or the date for the payment of any dividend, or the for the allotment of rights, or the date when any change or conversion or exchange of capital stock shall go into effect, or a date in connection with obtaining any such consent, as a date for the determination of the stockholders entitled to a notice of, and to vote at, any such meeting and any adjournment thereof, or entitled to receive payment of any such dividend, or to any such allotment of rights, or to exercise the rights in respect of any such change, conversion or exchange of capital stock, or to give such consent.
(c) If the stock ledgers shall be closed or a record date set for the purpose of determining stockholders entitled to notice or to vote at a meeting of stockholders, such books shall be closed for or such record date shall be at least ten days immediately preceding such meeting.
Section 6.07 Lost or Damaged Certificates. The corporation may issue a new certificate for stock or uncertificated securities of the corporation in place of any certificate theretofore issued by it alleged to have been lost or destroyed, and the board of directors may, in their discretion, require the owner of the lost or destroyed certificate or his legal representatives, to give the corporation a bond in such form and amount as the board of directors may direct, and with such surety or sureties as may be satisfactory to the board, to indemnify the corporation and its transfer agents and registrars, if any, against any claims that may be made against it or any such transfer agent or registrar on account of the issuance of such new certificate. A new certificate or uncertificated securities may be issued without requiring any bond when, in the judgment of the board of directors, it is proper to do so.
ARTICLE VII—EXECUTIVE COMMITTEE AND OTHER COMMITTEES
Section 7.01 How Constituted. The board of directors may designate an executive committee and such other committees as the board of directors may deem appropriate, each of which committees shall consist of one or more directors. Members of the executive committee and of any such other committee shall be designated annually at the annual meeting of the board of directors; provided however, that at any time the board of directors may abolish or reconstitute the executive committee or any such other committee. Each member of the executive committee and of any such other committee shall hold office until his successor shall have been designated or until his resignation or removal in the manner provided in these bylaws.
Section 7.02 Powers. During the intervals between meetings of the board of directors, the executive committee shall have and may exercise all powers of the board of directors in the management of the business and affairs of the corporation, except for the power to fill vacancies in the board of directors or to amend these bylaws, and except for such powers as by law may not be delegated by the board of directors to an executive committee.
Section 7.03 Proceedings. The executive committee and such other committees as may be designated hereunder by the board of directors, may fix its own presiding and recording officer or officers, and may meet at

 

11


 

such place or places, at such time or times and on such notice (or without notice) as it shall determine from time to time. It will keep record of its proceedings and shall report such proceedings to the board of directors at the meeting of board of directors next following.
Section 7.04 Quorum and Manner of Acting. At all meetings of the executive committee, and of such other committees as may be designated hereunder by the board of directors, the presence of members constituting a majority of the total authorized membership of the committee shall be necessary and sufficient to constitute a quorum for the transaction of business, and the act of a majority of the members present at, any meeting at which a quorum is preset shall be the act of such committee. The members of the executive committee and of such other committees as may be designated hereunder by the board of directors, shall act only as a committee, and the individual members thereof shall have no powers as such.
Section 7.05 Resignations. Any member of the executive committee, and of such other committees as may be designated hereunder by the board of directors, may resign at any time by delivering a written resignation to either the president, the secretary, or assistant secretary, or to the presiding officer of the committee of which he is a member, if any shall have been appointed and shall be in office. Unless otherwise specified therein, such resignation shall take effect on delivery.
Section 7.06 Removal. The board of directors may at ant any time remove any member of the executive committee or of any other committee designated by it hereunder either for or without cause.
Section 7.07 Vacancies. If any vacancy shall occur in the executive committee or of any other committee designated by the board of directors hereunder, by reason of disqualification, death, resignation, removal, or removal, or otherwise, the remaining members shall, until the filling of such vacancy, constitute the then total authorized membership of the committee and continued to act, unless such committee consisted of more than one member prior to the vacancy or vacancies and is left with only one member as a result thereof. Such vacancy may be filled at any meeting of the board of directors.
Section 7.08 Compensation. The board of directors may allow a fixed sum and expenses of attendance to any member of the executive committee, or of any other committee designated by it hereunder, who is not an active salaried employee of the corporation for attendance at each meeting of the said committee.
ARTICLE VIII—INDEMNIFICATION, INSURANCE AND
OFFICER AND DIRECTOR CONTRACTS
Section 8.01 Indemnification: Third Party Actions. The corporation shall have the power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending, or completed action, suit, or proceedings, or civil, criminal, administrative, or investigative (other than an action by or in the right of the corporation), by reason of the fact that he is or was a director, officer, employee, or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee, or agent of another, corporation, partnership, joint venture, trust, or other enterprise, against expenses (including attorneys fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred by him in connection with any such action, suit or proceeding, if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. The termination of any action, suit, or proceeding by judgment order, settlement, conviction, or a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation, and with respect to any criminal action or proceeding, he had reasonable cause to believe that his conduct was unlawful.
Section 8.02 Indemnification: Corporate Actions. The corporation shall have the power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending, or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that he is or was a director, officer, employee, or agent of the corporation, or is or was serving at the request of the corporation as a

 

12


 

director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise, against expenses (including attorneys’ fees) actually and reasonably incurred by him in connection with the defense or settlement of such action or suit, if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification shall be made in respect of any claim, issue, or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the court in which such action or suit was brought shall determine on application that despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.
Section 8.03 Determination. To the extent that a director, officer, employee, or agent of the corporation has been successful on the merits or otherwise in defense of any action, suit, or proceeding referred to in sections 8.01 and 8.02 hereof, or in defense of any claim, issue, or matter therein, he shall be indemnified against expenses (including attorneys’ fees) actually and reasonably incurred by him in connection therewith. Any other indemnification under sections 8.01 or 8.02 hereof, unless ordered by a court shall be made by the corporation only in the specific case on a determination that indemnification of the director, officer, employee, or agent is proper in the circumstances because he has met the applicable standard or conduct set forth in sections 8.01 or 8.02 hereof. Such determination shall be made either (i) by the board of directors by a majority vote of quorum consisting of directors who were not parties to such action, suit, or proceeding, (ii) if such a quorum is not obtainable, or, even if obtainable a quorum of disinterested directors so directs, by independent legal counsel in a written opinion, or (iii) by the stockholders by a majority vote of a quorum of stockholders at any meeting duly called for such purpose.
Section 8.04 Advances. Expenses incurred by an officer or director in defending a civil or criminal action, suit, or proceeding may be paid by the corporation in advance of the final disposition of such action, suit, or proceeding on receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be determined that he is not entitled to be indemnified by the corporation as authorized by this section. Such expenses incurred by other employees and agents may be so paid on such terms and conditions, if any, as the board of directors deems appropriate.
Section 8.05 Scope of Indemnification. The indemnification and advancement of expenses provided by, or granted pursuant to, sections 8.01, 8.02, and 8.04:
(a) Shall not be deemed exclusive of an other rights to which those seeking indemnification or advancement of expenses may be entitled, under any bylaw, agreement, vote of stockholders or disinterested directors, or otherwise, as to action in his official capacity and as to action in another capacity while holding such office; and
(b) Shall, unless otherwise provided when authorized or ratified, continue as to a person who ceased to be a director, officer, employee, or age of the corporation, and shall inure to the benefit of the heirs, executors, and administrators of such a person.
Section 8.06 Insurance. The corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee, or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise against any liability asserted against him and incurred by him in any such capacity or arising out of his status as such, whether or not the corporation would have the power to indemnify him against any such liability.
Section 8.07 Officer and Director Contracts. No contract or other transaction between the corporation and one or more of its directors or officers, or between the corporation and any corporation, partnership, association, or other organization in which one or more of the corporation’s directors or officers are directors, officers, or have a financial interest, is either void or voidable solely on the basis of such relationship or solely because any such director or officer is present at or participates in the meeting of the board of directors or a committee thereof which authorizes the contract or transaction, or solely because the vote or votes of each director or officer are counted for such purpose, if:

 

13


 

(a) The material facts of the relationship or interest are disclosed or known to the board of directors or committee and the board or committee in good faith authorizes the contract or transaction by the affirmative votes of a majority of the disinterested directors even though the disinterested directors be less than a quorum;
(b) The material facts of the relationship or interest is disclosed or known to the stockholders and they approve or ratify the contract or transaction in good faith by a majority vote of the shares voted at a meeting of stockholders called for such purpose or written consent of stockholders holding a majority of the shares entitled to vote (the votes of the common or interested directors or officers shall be counted in any such vote of stockholders); or
(c) The contract or transaction is fair as to the corporation at the time it is authorized, approved, or ratified by the board of directors, a committee thereof, or the stockholders.
ARTICLE IX—FISCAL YEAR
The fiscal year of the corporation shall be fixed by resolution of the board of directors.
ARTICLE X—DIVIDENDS
The board of directors may from time to time declare, and the corporation may pay, dividends on its outstanding stock in the manner and on the terms and conditions provided by the certificate of incorporation and by laws.
ARTICLE XI—AMENDMENTS
All bylaws of the corporation, whether adopted by the board of directors or the stockholders, shall be subject to amendment, alteration, or repeal, and new bylaws may be made, except that:
(a) No bylaw adopted or amended by the stockholders shall be altered or repealed by the board of directors; and
(b) No bylaw shall be adopted by the board directors which shall require more than the stock representing a majority of the voting power for a quorum at a meeting of stockholders, or more than a majority of the votes cast to constitute action by the stockholders, except where higher percentages are required by law, provided, however , that
(i) If any bylaw regulating an impending election of directors is adopted or amended or repealed by the board of directors, there shall be set forth in the notice of the next meeting of the stockholders for the election of directors, the bylaws so adopted or amended or repealed, together with a concise statement of the changes made; and
(ii) No amendment, alteration, or repeal of this article XI shall be made except by the stockholders.

 

14

Exhibit 99.1
IN THE UNITED STATES BANKRUPTCY COURT
FOR THE DISTRICT OF DELAWARE
         
 
       
In re:
  :   Chapter 11
 
  :    
Isolagen, Inc., et al., 1
  :   Case No. 09-12072 (MFW)
 
  :    
Debtor.
  :   Jointly Administered
 
  :    
 
       
FIRST AMENDED DISCLOSURE STATEMENT TO ACCOMPANY THE
CHAPTER 11 PLAN OF REORGANIZATION PROPOSED BY

DEBTORS IN POSSESSION
CIARDI CIARDI & ASTIN
Daniel K. Astin (No. 4068)
Anthony M. Saccullo (No. 4141)
Mary E. Augustine (No. 4477)
Carl D. Neff (No. 4895)
919 N. Market Street, Suite 700
Wilmington, Delaware 19801
Tel: (302) 658-1100
Fax: (302) 658-1300
dastin@ciardilaw.com
asaccullo@ciardilaw.com
maugustine@ciardilaw.com
cneff@ciardilaw.com
Counsel to the Debtors
Dated: July 30, 2009
            Wilmington, Delaware
THE PLAN SUMMARIZED HEREIN AND ATTACHED HERETO IS THE RESULT OF EXTENSIVE NEGOTIATIONS AMONG PRE-PETITION LENDERS AS WELL AS THE DIP FACILITY LENDERS AND THE DEBTORS. AS A RESULT, THE DEBTORS BELIEVE THAT THE PLAN PROVIDES THE BEST POSSIBLE RESULT FOR ALL HOLDERS OF CLAIMS, AND THEREFORE, ACCEPTANCE OF THE PLAN IS IN THE BEST INTERESTS OF THE DEBTORS’ CREDITORS AND INTEREST HOLDERS. THE DEBTORS STRONGLY URGE ALL HOLDERS OF CLAIMS TO ACCEPT THE PLAN.
     
 
1  
The Debtors are Isolagen, Inc., tax identification number **-***8888, and Isolagen Technologies, Inc., tax identification number **-***6974.

 

 


 

TABLE OF CONTENTS
         
    Page  
 
       
I. INTRODUCTION
    3  
 
       
A. General Description of the Chapter 11 Reorganization Process:
    3  
B. Overview of the Plan Process in these Cases:
    4  
C. Holders of Claims Entitled to Vote
    4  
D. Voting Procedures
    5  
E. Confirmation Hearing
    6  
F. Disclaimers and Notices
    6  
G. Recommendation by the Debtors
    7  
 
       
II. GENERAL INFORMATION
    7  
 
       
A. Description and History of the Debtor’s Business
    7  
B. Existing Indebtedness
    9  
C. Equity Interests
    11  
D. Events Leading to Bankruptcy
    11  
 
       
III. THE CHAPTER 11 CASES
    12  
 
       
IV. SUMMARY OF THE PLAN
    12  
 
       
A. General Framework of the Plan
    12  
B. Distributions under the Plan
    13  
C. Administrative Expense Claims, Priority Tax Claims, Priority Non-Tax Claims, and DIP Facility Claims
    16  
D. Exit Financing
    17  
E. Management Incentive Plan
    18  
F. Permanent Injunction, Release & Exculpation
    18  
G. Bar Date
    21  
H. Executory Contracts
    22  
I. Consolidation for Distribution and Voting Purposes
    22  
 
       
V. CONFIRMATION AND CONSUMMATION OF THE PLAN
    22  
 
       
A. The Confirmation Hearing
    23  
B. Confirmation of the Plan
    23  
C. Consummation of the Plan
    27  
 
       
VI. RISK FACTORS TO BE CONSIDERED
    27  
 
       
A. Certain Risks of Non-Confirmation
    27  
B. Risks of Non-Consummation of Plan
    29  
C. Risks Associated with New Common Stock
    29  
 
       
VII. EXEMPTIONS FROM SECURITIES ACT REGISTRATION
    30  

 

1


 

         
    Page  
 
       
A. Generally:
    30  
B. Initial Issuance of New Common Stock under the Plan
    30  
 
       
VIII. ALTERNATIVES TO CONFIRMATION AND CONSUMMATION OF THE PLAN
    31  
 
       
A. Liquidation under Chapter 7 or Chapter 11
    32  
B. Alternative Plan of Reorganization
    32  
 
       
IX. CERTAIN FEDERAL INCOME TAX CONSEQUENCES OF THE PLAN
    32  
 
       
A. Consequences to Holders of Allowed Claims in Classes 1, 3, and 4
    33  
B. Consequences to the Debtors
    34  
 
       
X. CONCLUSION AND RECOMMENDATION
    36  

 

2


 

THIS DISCLOSURE STATEMENT IS DESIGNED TO SOLICIT YOUR ACCEPTANCE OF THE ATTACHED PLAN AND CONTAINS INFORMATION RELEVANT TO YOUR DECISION. PLEASE READ THIS DISCLOSURE STATEMENT, THE PLAN, AND THE OTHER MATERIALS COMPLETELY AND CAREFULLY. THE PLAN IS ATTACHED AS EXHIBIT “A” TO THIS DISCLOSURE STATEMENT. PLAN SUMMARIES AND STATEMENTS MADE IN THIS DISCLOSURE STATEMENT ARE QUALIFIED IN THEIR ENTIRETY BY REFERENCE TO THE PLAN, OTHER EXHIBITS ATTACHED HERETO, AND OTHER DOCUMENTS REFERENCED AS FILED WITH THE BANKRUPTCY COURT BEFORE OR CONCURRENTLY WITH THE FILING OF THIS DISCLOSURE STATEMENT.
FURTHERMORE, THE PROJECTED FINANCIAL INFORMATION CONTAINED HEREIN HAS NOT BEEN THE SUBJECT OF AN AUDIT. SUBSEQUENT TO THE DATE HEREOF, THERE CAN BE NO ASSURANCE THAT: (A) THE INFORMATION AND REPRESENTATIONS CONTAINED HEREIN WILL CONTINUE TO BE MATERIALLY ACCURATE; (B) THE DISCLOSURE STATEMENT CONTAINS ALL MATERIAL INFORMATION; OR (C) THE FINANCIAL INFORMATION SET FORTH HEREIN COMPLIES WITH GENERALLY ACCEPTED ACCOUNTING STANDARDS.
HOLDERS OF IMPAIRED CLAIMS OR INTERESTS ARE ENCOURAGED TO READ AND CAREFULLY CONSIDER THE MATTERS DESCRIBED IN THIS DISCLOSURE STATEMENT, INCLUDING THOSE UNDER “RISK FACTORS,” PRIOR TO SUBMITTING BALLOTS VOTING ON THE PLAN. IN MAKING A DECISION TO ACCEPT OR REJECT THE PLAN, EACH HOLDER OF AN IMPAIRED CLAIM MUST RELY ON ITS OWN EXAMINATION OF THE DEBTORS AS DESCRIBED IN THIS DISCLOSURE STATEMENT AND THE TERMS OF THE PLAN, INCLUDING THE MERITS AND RISKS INVOLVED. IN ADDITION, CONFIRMATION AND CONSUMMATION OF THE PLAN ARE SUBJECT TO CONDITIONS PRECEDENT THAT COULD LEAD TO DELAYS IN CONSUMMATION OF THE PLAN. THERE CAN BE NO ASSURANCE THAT EACH OF THESE CONDITIONS WILL BE SATISFIED OR WAIVED (AS PROVIDED IN THE PLAN) OR THAT THE PLAN WILL BE CONSUMMATED. EVEN AFTER THE EFFECTIVE DATE, DISTRIBUTIONS UNDER THE PLAN MAY BE SUBJECT TO SUBSTANTIAL DELAYS FOR HOLDERS OF CLAIMS THAT ARE DISPUTED.
THE DEBTORS WILL REQUEST THAT THE BANKRUPTCY COURT CONFIRM THE PLAN UNDER BANKRUPTCY CODE SECTION 1129(b) , WHICH PERMITS CONFIRMATION OF THE PLAN DESPITE REJECTION BY ONE OR MORE CLASSES IF THE BANKRUPTCY COURT FINDS THAT THE PLAN “DOES NOT DISCRIMINATE UNFAIRLY” AND IS “FAIR AND EQUITABLE” AS TO THE CLASS OR CLASSES THAT DO NOT ACCEPT THE PLAN. THE DEBTORS WILL REQUEST THAT THE BANKRUPTCY COURT FIND THAT THE PLAN IS FAIR AND EQUITABLE AND DOES NOT DISCRIMINATE UNFAIRLY AS TO ANY CLASS THAT FAILS TO ACCEPT THE PLAN.

 

1


 

NO PARTY IS AUTHORIZED BY THE DEBTORS TO GIVE ANY INFORMATION OR MAKE ANY REPRESENTATIONS WITH RESPECT TO THE PLAN OTHER THAN THAT WHICH IS CONTAINED IN THIS DISCLOSURE STATEMENT. NO REPRESENTATIONS OR INFORMATION CONCERNING THE DEBTORS, THEIR FUTURE BUSINESS OPERATIONS, OR THE VALUE OF THEIR PROPERTIES HAVE BEEN AUTHORIZED BY THE DEBTORS OTHER THAN AS SET FORTH HEREIN.
THIS DISCLOSURE STATEMENT HAS BEEN PREPARED IN ACCORDANCE WITH SECTION 1125 OF THE BANKRUPTCY CODE AND NOT IN ACCORDANCE WITH FEDERAL OR STATE SECURITIES LAWS OR OTHER APPLICABLE NON-BANKRUPTCY LAWS. ENTITIES HOLDING, TRADING IN, OR OTHERWISE PURCHASING, SELLING, OR TRANSFERRING CLAIMS AGAINST, INTERESTS IN, OR SECURITIES OF THE DEBTORS SHOULD EVALUATE THIS DISCLOSURE STATEMENT ONLY IN LIGHT OF THE PURPOSE FOR WHICH IT WAS PREPARED.
IF THE REQUISITE ACCEPTANCES OF THE PLAN ARE RECEIVED, THE PLAN IS CONFIRMED BY THE BANKRUPTCY COURT, AND THE EFFECTIVE DATE OCCURS, ALL HOLDERS OF CLAIMS OR INTERESTS (INCLUDING THOSE WHO DO NOT SUBMIT BALLOTS TO ACCEPT OR TO REJECT THE PLAN AND THE TRANSACTIONS CONTEMPLATED THEREBY) WILL BE BOUND BY THE PLAN AND THE TRANSACTIONS CONTEMPLATED THEREBY—INCLUDING, WITHOUT LIMITATION, THE RELEASES AND EXCULPATIONS SET FORTH IN THE PLAN.
THIS DISCLOSURE STATEMENT HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION OR BY ANY STATE SECURITIES COMMISSION OR SIMILAR PUBLIC, GOVERNMENTAL, OR REGULATORY AUTHORITY, AND NEITHER SUCH COMMISSION NOR ANY SUCH AUTHORITY HAS PASSED UPON THE ACCURACY OR ADEQUACY OF THE STATEMENTS CONTAINED HEREIN.
THE STATEMENTS CONTAINED IN THIS DISCLOSURE STATEMENT ARE MADE AS OF THE DATE HEREOF AND NEITHER THE DELIVERY OF THIS DISCLOSURE STATEMENT, NOR ANY DISTRIBUTION OF PROPERTY PURSUANT TO THE PLAN, WILL CREATE ANY IMPLICATION THAT THE INFORMATION CONTAINED HEREIN IS CORRECT AS OF ANY TIME SUBSEQUENT TO THE DATE HEREOF, OR THAT THERE HAS BEEN NO CHANGE IN THE INFORMATION SET FORTH HEREIN OR IN THE AFFAIRS OF THE DEBTORS SINCE THE DATE HEREOF.
EACH CREDITOR OF THE DEBTORS SHOULD CONSULT WITH SUCH CREDITOR’S LEGAL, BUSINESS, FINANCIAL, AND TAX ADVISORS AS TO ANY SUCH MATTERS CONCERNING THE SOLICITATION OF VOTES TO ACCEPT OR REJECT THE PLAN AND THE TRANSACTIONS CONTEMPLATED THEREBY.

 

2


 

I. INTRODUCTION
Isolagen, Inc. (“Isolagen”) and Isolagen Technologies, Inc. (“Isolagen Tech”), debtors and debtors in possession (collectively, the “Debtors” or the “Company”) in the above-captioned cases, by and through their counsel, hereby submit this Disclosure Statement pursuant to section 1125 of title 11 of the United States Code (the “Bankruptcy Code”) to Holders 2 of Claims against, and Interests in, the Debtors in connection with: (i) the solicitation of acceptances to the Plan of Reorganization Proposed by the Debtors and Filed by the Debtors with the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”); and (ii) the hearing before the Bankruptcy Court to consider confirmation of the Plan (the “Confirmation Hearing”).
A. General Description of the Chapter 11 Reorganization Process:
Chapter 11 is the principal business reorganization chapter of the Bankruptcy Code. Under Chapter 11, a debtor is authorized to reorganize its business for the benefit of itself, its creditors, and its equity interest holders. In addition to permitting rehabilitation of a debtor, another goal of Chapter 11 is to promote equality of treatment of similarly-situated creditors and equity interest holders with respect to the distribution of a debtor’s assets. The filing of a Chapter 11 petition creates an estate that is comprised of all of the legal and equitable property interests of the debtor as of the petition date. The Bankruptcy Code provides that the debtor may continue to operate its business and remain in possession of its property as a “debtor in possession.”
The consummation of a plan of reorganization is the principal objective of a Chapter 11 case. A plan of reorganization sets forth the means for satisfying claims against, and equity interests in, a debtor. Confirmation of a plan of reorganization by the Bankruptcy Court makes the plan binding upon a debtor, any issuer of securities under the plan, any person acquiring property under the plan, and any creditor or equity interest holder of a debtor. Subject to certain limited exceptions, the confirmation order discharges a debtor from any debt that arose prior to the date of plan confirmation and substitutes the obligations specified under the confirmed plan.
After a plan of reorganization has been filed, the holders of impaired claims against, or equity interests in, a debtor are permitted to vote to accept or reject the plan. Before soliciting acceptances of the proposed plan, however, Section 1125 of the Bankruptcy Code requires the proponent to prepare a disclosure statement containing adequate information of a kind, and in sufficient detail, to enable a hypothetical reasonable investor to make an informed judgment about the plan.
Attached as Exhibits to this Disclosure Statement (the “Disclosure Statement”) are copies of the following:
   
The Plan (Exhibit “A”)
 
   
An order of the Bankruptcy Court (the “Disclosure Statement Order”), approving the Disclosure Statement and establishing certain procedures with respect to the solicitation and tabulation of votes to accept or reject the Plan (Exhibit “B”)
 
     
2  
Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Plan.

 

3


 

   
Liquidation Analysis prepared by Miller Coffey Tate LLP (MCT) as financial advisor to the Debtors (Exhibit “C”)
 
   
Projected Operations for 12 months post-confirmation (Exhibit “D”)
 
   
The Restructuring Agreement with incorporated term sheet (Exhibit “E”)
In addition, a Ballot for the acceptance or rejection of the Plan submitted to Holders of Claims entitled to vote to accept or reject the Plan is enclosed with this Disclosure Statement.
B. Overview of the Plan Process in these Cases:
On the Petition Date, the Debtors each filed a voluntary petition under Chapter 11 of the Bankruptcy Code. On or about June 26, 2009, the Debtors filed the Plan and Disclosure Statement with the Bankruptcy Court pursuant to Section 1125 of the Bankruptcy Code and in connection with the solicitation of votes to accept or reject the Plan.
After notice and a hearing, the Bankruptcy Court determined that this Disclosure Statement contained “adequate information” of a kind, and in sufficient detail, to enable hypothetical, reasonable investors typical of the Debtors’ creditors to make an informed judgment about the Plan. Accordingly, the Bankruptcy Court signed the Disclosure Statement Order approving this Disclosure Statement.
The Disclosure Statement Order, a copy of which is annexed to this Disclosure Statement as Exhibit “B,” sets forth in detail the deadlines, procedures, and instructions for voting to accept or reject the Plan, and for filing objections to confirmation of the Plan, the record date for voting purposes, and the applicable standards for tabulating Ballots. In addition, detailed voting instructions accompany each Ballot. Each holder of a Claim entitled to vote to accept or reject the Plan should read the Disclosure Statement, the Plan, the Disclosure Statement Order, and the instructions accompanying the Ballots in their entirety before voting on the Plan.
C. Holders of Claims Entitled to Vote
Under the Plan, only Classes 1, 3, and 4 are entitled to vote on the Plan because they are impaired and will receive a distribution under the Plan. Accordingly, the Debtors are soliciting acceptances only from the Holders of Allowed Claims in Classes 1, 3, and 4. Holders of Claims in Class 6 and Interests in Class 5 are impaired and will receive no distribution under the Plan, and thus, are conclusively presumed to have rejected the Plan—so no vote will be solicited from Holders in Classes 5 and 6.
The Bankruptcy Code defines “acceptance” of a plan by a class of claims or interests as acceptance by creditors in that class that hold at least two-thirds in dollar amount and more than one-half in number of the claims that cast ballots for acceptance or rejection of the proposed plan of reorganization.
The Debtors reserve the right to amend the Plan and intend to request confirmation of the Plan pursuant to Section 1129(b) of the Bankruptcy Code, which would enable the Plan to be

 

4


 

confirmed regardless of the rejection of the Plan by one or more classes of impaired Claims or Interests entitled to vote. Under Section 1129(b) of the Bankruptcy Code, the Plan may be confirmed if at least one class of impaired Claims accepts the Plan (excluding the votes of insiders) and the Plan does not “discriminate unfairly” and is “fair and equitable” with respect to each non-accepting class. For a more detailed description of the requirements for confirmation of the Plan pursuant to Section 1129(b) of the Bankruptcy Code, see “Confirmation of the Plan” set forth herein.
D. Voting Procedures
If you are entitled to vote to accept or reject the Plan, a Ballot is enclosed for the purpose of voting on the Plan. If you hold Claims in more than one Class and each of those Classes is entitled to vote, you will receive separate Ballots for each such Class which must be returned for each separate Class of Claims.
Pursuant to the Disclosure Statement Order, the Bankruptcy Court set June 22, 2009, as the record date for voting on the Plan. Accordingly, only Holders of record as of June 22, 2009, that are otherwise entitled to vote on the Plan will receive a Ballot and may vote on the Plan.
All other creditors entitled to vote on the Plan must return their Ballot(s) to the following address:
Reliable
Attn: Isolagen Ballots
1007 North Orange Street
Wilmington, DE 19801
FOR YOUR BALLOT TO BE COUNTED, YOU MUST RETURN IT TO THE ADDRESS SET FORTH ON THE BALLOT SO THAT IT IS ACTUALLY RECEIVED BY 4:00 P.M. PREVAILING EASTERN TIME ON OR BEFORE THE VOTING DEADLINE SET FORTH IN THE ATTACHED DISCLOSURE STATEMENT ORDER (THE “VOTING DEADLINE”). BALLOTS MUST BE DELIVERED BY MAIL, COURIER, OR OTHER DELIVERY SERVICE—FACSIMILE BALLOTS WILL NOT BE ACCEPTED. ANY EXECUTED BALLOT RECEIVED THAT DOES NOT INDICATE EITHER AN ACCEPTANCE OR REJECTION OF THE PLAN SHALL NOT BE COUNTED.
Any Holder of a Claim who is entitled to vote under the Plan and who has Filed a Proof of Claim in these Cases shall be entitled to vote in the amount of the value of the Proof of Claim, unless an objection or request for estimation is pending with regard to the Claim. Any Holder of a Claim listed by the Debtors on their Schedules of Assets and Liabilities for which no Proof of Claim has been filed, shall be entitled to vote in the amount Scheduled by the Debtors. In the event that no valid Proof of Claim or Interest is Filed, and the Claim or Interest is not Scheduled by the Debtors in a fixed amount, a Holder of a Claim or Interest must set forth a fixed, liquidated amount for such Claim on the Ballot. The Holder will be permitted to vote in the amount listed on the Ballot unless: (i) a motion to estimate the claim is filed; or (ii) the Claim set forth on the Ballot is subject to an objection on the date or dates during which the confirmation hearing is held.

 

5


 

If you have any questions about the Plan, the Disclosure Statement, or the procedures for voting, please call Daniel K. Astin, Esquire, at Ciardi Ciardi & Astin, counsel to the Debtors at (302) 658-1100.
E. Confirmation Hearing
The hearing to consider confirmation of the Plan (the “Confirmation Hearing”) will be held on July 27, 2009 at 4:00 p.m. (Prevailing Eastern Time) before the Honorable Mary F. Walrath, United States Bankruptcy Judge, at the United States Bankruptcy Court, 824 Market Street, 5 th Floor, Courtroom 4, Wilmington, Delaware 19801. In the attached Disclosure Statement Order, the Bankruptcy Court has established the deadline by which objections, if any, to confirmation of the Plan must be served and filed. The Confirmation Hearing may be adjourned from time to time by the Bankruptcy Court without further notice except for the announcement of the adjournment date made at the Confirmation Hearing or any subsequent adjourned Confirmation Hearing.
F. Disclaimers and Notices
The statements contained in this Disclosure Statement are made as of the date hereof unless another time is specified, and the delivery of this Disclosure Statement shall not create an implication that there has been no change in the information since the date hereof.
Any representations or inducements made to secure your acceptance or rejection of the Plan, other than as contained in this Disclosure Statement or the Plan, should not be relied upon in arriving at your decision, and should be reported to counsel to the Debtors, Daniel K. Astin, Esquire, at 302-658-1100.
Much of the information contained herein (including in the Exhibits to the Disclosure Statement) has not been subject to a certified audit. Accordingly, the Debtors are unable to warrant or represent that the information contained herein (including in the Exhibits to the Disclosure Statement) is without any inaccuracy, or complies with generally accepted accounting standards. However, reasonable efforts have been made to ensure accuracy.
For the convenience of Holders of Claims and Interests, this Disclosure Statement summarizes the terms of the Plan, but those summaries are qualified in their entirety by the Plan itself. In the event of any inconsistencies between the Plan and the Disclosure Statement, the Plan is controlling.
The Disclosure Statement may not be relied upon for any purpose other than: (i) to determine whether to vote to accept or reject the Plan; and (ii) to object to the Plan at the Confirmation Hearing. Nothing in this Disclosure Statement shall constitute an admission of any fact or liability by any person, or be admissible in any proceeding involving the Debtors, or any other person, or be deemed conclusive evidence of the tax or other legal effects of the Plan on the Debtors or holders of Claims or Interests.
Certain of the statements contained in this Disclosure Statement are forward-looking and contain estimates and assumptions. There can be no assurance that such statements will be

 

6


 

reflective of actual outcomes. All holders of Claims should carefully read and consider fully the “Risk Factors to Be Considered,” as set forth herein before voting to accept or reject the Plan.
G. Recommendation by the Debtors
AS PROPONENTS OF THE PLAN, THE DEBTORS SUPPORT THE CONFIRMATION OF THE PLAN. THE DEBTORS BELIEVE THAT THE PLAN PROVIDES THE BEST POSSIBLE RECOVERIES TO CREDITORS AND THAT ACCEPTANCE OF THE PLAN IS IN THE BEST INTERESTS OF CREDITORS. ACCORDINGLY, THE DEBTORS RECOMMEND THAT ELIGIBLE CREDITORS VOTE TO ACCEPT THE PLAN.
II. GENERAL INFORMATION
A. Description and History of the Debtor’s Business
Isolagen is a Delaware corporation principally located at 405 Eagleview Boulevard in Exton, Pennsylvania, and is the parent company of Isolagen Tech, a Delaware corporation with the same principal location as Isolagen. Isolagen Tech is wholly owned by Isolagen. Isolagen also has a 57% interest in Agera Laboratories, Inc., a Delaware corporation (“Agera”). Isolagen Tech wholly owns Isolagen Europe Limited, a company organized under the laws of the United Kingdom (“Isolagen Europe”), Isolagen Australia Pty Limited, a company organized under the laws of Australia (“Isolagen Australia”), and Isolagen International, S.A., a company organized under the laws of Switzerland (“Isolagen Switzerland”, collectively, with all Isolagen entities, the “Company”). The common stock of Isolagen, par value $0.001 per share, (“Common Stock”) is listed on the NYSE Amex exchange (formerly known as the American Stock Exchange or “AMEX”) under the symbol “ILE.” However, the trading of its stock was halted by AMEX in May 2009 and is expected to be delisted soon.
The Debtors are aesthetic and therapeutic companies focused on developing novel skin and tissue rejuvenation products. The Debtors clinical development product candidates are designed to improve the appearance of skin injured by the effects of aging, sun exposure, acne and burns with a patient’s own, or autologous, fibroblast cells produced by the Company’s proprietary Isolagen Process. The Company also has a skin care line through its Agera Laboratories, Inc. (“Agera”) subsidiary.
Isolagen acquired 57% of the outstanding common shares of Agera on August 10, 2006. Agera offers a complete line of skincare systems based on a wide array of proprietary formulations, trademarks and nano-peptide technology. These skincare products can be packaged to offer anti-aging, anti-pigmentary and acne treatment systems. Agera markets its product in both the United States and Europe (primarily the United Kingdom) via third party distributors primarily.
In October 2006, the Company reached an agreement with the FDA on the design of a Phase III pivotal study protocol for the treatment of nasolabial folds. The randomized, double-blind protocol was submitted to the FDA under the agency’s Special Protocol Assessment (“SPA”) regulations. Pursuant to this assessment process, the FDA has agreed that the

 

7


 

Company’s study design for two identical trials, including patient numbers, clinical endpoints, and statistical analyses, is acceptable to the FDA to form the basis of an efficacy claim for a marketing application. The randomized, double-blind, pivotal Phase III trials will evaluate the efficacy and safety of Isolagen Therapy against placebo in approximately 400 patients with approximately 200 patients enrolled in each trial. The Company completed enrollment of the study and commenced injection of subjects in early 2007. All injections were completed in January 2008 and top line results from this trial were publically announced in August 2008. The data analysis, including safety data, was publically released in October 2008. The related Biologics License Application (“BLA”) was submitted to the FDA in March 2009. The BLA was accepted for filing by the FDA in May 2009, and the Debtors are currently waiting for approval from the FDA to market its product.
The Debtors’ business model is a biotechnology company focused on developing emergent, novel skin and tissue rejuvenation products for application in certain aesthetic and therapeutic markets. Isolagen was founded in 1995, specializing in the development of the Isolagen Process™, the innovative cellular processing system which creates the Isolagen Therapy™. With seven secured U.S. patents and nine additional U.S. patents pending, Isolagen has an overall approach to aesthetic and therapeutic cellular rejuvenation. Specifically, the Isolagen Therapy has broad potential as a personalized treatment for wrinkles, acne scars, burn scars and periodontal disease.
The Isolagen® Process is a novel process whereby a patient’s own collagen-producing cells (fibroblasts) are multiplied to create a living cell therapy which can be returned to the patient’s skin. Unlike other applications for the treatment of dermal defects, the Isolagen Therapy is produced utilizing only the patient’s unique, living cells. By multiplying a patient’s own collagen-producing cells or fibroblasts into tens of millions of new cells, a personalized treatment is created which is then returned to the patient’s skin. This treatment, known as the Isolagen Therapy™, is designed to improve skin damage caused by the normal effects of aging, sun damage, acne and burns. Phase III clinical trials were completed in 2008 to evaluate the efficacy and safety of Isolagen Therapy in treating nasolabial folds or wrinkles. A Phase II open-label clinical trial to evaluate the use of Isolagen Therapy to treat fine lines and wrinkles for the full face was also completed in 2008.
In addition to wrinkle correction, Isolagen also conducted a Phase II/III clinical program to investigate Isolagen Therapy™ for the treatment of moderate to severe acne scars. Isolagen is planning clinical trials for the treatment of burn scars (Phase II), which is currently on hold. Isolagen’s aesthetics development programs include product candidates to treat targeted areas or wrinkles and to provide full-face rejuvenation that includes the improvement of fine lines, wrinkles, skin texture and appearance. The therapeutic development programs are primarily designed to treat acne scars and restrictive burn scars. All of the product candidates are non-surgical and minimally invasive.
Through December 31, 2008, the Company has been primarily engaged in developing its product technology. In the course of its development activities, the Debtors have sustained losses and expect such losses to continue through at least 2009. The Debtors’ ability to operate profitably is largely contingent upon its success in obtaining financing, obtaining regulatory approval to sell one or a variety of applications of the Isolagen Therapy, upon its successful

 

8


 

development of markets for its products and upon the development of profitable saleable manufacturing processes. As of December 31, 2008, the Debtors had cash and cash equivalents of $2.9 million and negative working capital of $87.3 million.
B. Existing Indebtedness
Unsecured Debt . On November 3, 2004, Isolagen, Inc. (“Isolagen”) completed the private placement of $75.0 million aggregate principal amount of 3.5% Convertible Subordinated Notes Due 2024 (the “3.5% Subordinated Notes”). The 3.5% Subordinated Notes could be due sooner than 2024, as discussed below. Isolagen received net proceeds of approximately $71.7 million after the deduction of commissions and offering expenses. Isolagen also granted the purchasers of the 3.5% Subordinated Notes the option to purchase up to $15.0 million of additional 3.5% Subordinated Notes through December 2, 2004.
On November 5, 2004, Isolagen completed the private placement of the additional $15.0 million aggregate principal amount of 3.5% Subordinated Notes. Isolagen received net proceeds of approximately $14.5 million after the deduction of discounts, commissions and offering expenses. The total net proceeds to Isolagen were approximately $86.2 million after the deduction of commissions and offering expenses.
Isolagen used approximately $26 million of the net proceeds to repurchase 4,000,000 shares of its common stock, of which 2,000,000 shares were repurchased from former officers, shareholders, and members of the board of directors. The remaining net proceeds of approximately $60.2 million were added to Isolagen’s general working capital.
The 3.5% Subordinated Notes are unsecured obligations and are subordinated in right of payment to all of Isolagen’s existing and future senior indebtedness. The 3.5% Subordinated Notes are also effectively subordinated to all indebtedness and other liabilities of Isolagen’s subsidiaries.
The 3.5% Subordinated Notes require the semi-annual payment of interest, on May 1 and November 1 of each year beginning May 1, 2005, at 3.5% interest per annum on the principal amount outstanding. The 3.5% Subordinated Notes will mature on November 1, 2024. Prior to maturity, the holders may convert their 3.5% Subordinated Notes into shares of Isolagen’s common stock. The initial conversion rate is 109.2001 shares per $1,000 principal amount of 3.5% Subordinated Notes, which is equivalent to an initial conversion price of approximately $9.16 per share.
On or after November 1, 2009, Isolagen may, at its option, redeem the 3.5% Subordinated Notes, in whole or in part, for cash, at a redemption price equal to 100% of the principal amount of the 3.5% Subordinated Notes to be redeemed plus accrued and unpaid interest.
On each of November 1, 2009, November 1, 2014 and November 1, 2019, the holders may require Isolagen to purchase all or a portion of their 3.5% Subordinated Notes at a purchase price in cash equal to 100% of the principal amount of 3.5% Subordinated Notes to be purchased plus accrued and unpaid interest. The holders of the 3.5% Subordinated Notes may also require Isolagen to repurchase their 3.5% Subordinated Notes in the event its common stock (or other

 

9


 

common stock into which the 3.5% Convertible Subordinated Notes are then convertible) ceases to be listed for trading on a U.S. national securities exchange or approved for trading on an established automated over-the-counter market in the United States.
In the event a change in control occurs on or before November 9, 2009, the holders of the 3.5% Subordinated Notes may require Isolagen to purchase all or a portion of their notes at a purchase price equal to 100% of the principal amount of the 3.5% Subordinated Notes to be purchased plus accrued and unpaid interest and the payment of a “make-whole” payment which is based on the date on which the change in control occurs and the price per share paid for Isolagen’s common stock in such change in control transaction. Isolagen will be allowed to pay for the repurchase of the 3.5% Subordinated Notes and accrued and unpaid interest in cash or, at its option, shares of its common stock, and Isolagen will be allowed to make the make-whole payment in cash or, at its option, such other form of consideration as is paid to its common stockholders in the change in control transaction. In addition, in the event a change in control occurs on or before November 9, 2009, the holders of the 3.5% Subordinated Notes that convert their 3.5% Subordinated Notes into shares of Isolagen’s common stock in connection with such change in control transaction will also be entitled to receive the make-whole payment.
The 3.5% Subordinated Notes were issued in an offering not registered under the Securities Act of 1933, as amended (the “Securities Act”). However, Isolagen was obligated to file with the SEC a shelf registration statement covering resales of the 3.5% Subordinated Notes and the shares of Isolagen’s common stock issuable upon the conversion of the 3.5% Subordinated Notes. The shelf registration statement was subsequently declared effective on May 2, 2005. As of December 31, 2008, Isolagen has recorded the 3.5% Subordinated Notes as a current liability on the accompanying consolidated balance sheet as the holders may require Isolagen to purchase all of the 3.5% Subordinated Notes as early as November 2009.
Unsecured Trade Debt . Aside from the 3.5% Subordinated Notes, the majority of the Debtors’ unsecured debt consists of general trade debt for suppliers of goods and services in the approximate amount of $725,000. In addition, the Debtors have certain outstanding debt and obligations related to their lease of their facility and lawsuits that have been commenced against them. Specifically, the Debtors are liable for the payment of $325,000 to settle a derivative lawsuit.
Secured Debt . On April 30, 2009, Isolagen entered into secured promissory notes and security agreements (the “Notes”) with eight lenders pursuant to which Isolagen borrowed an aggregate of $500,417.00 in principal amount. The Notes bear interest at a rate of 20% per annum with principal and interest on the Notes due on the earlier of June 20, 2009 or the date that Isolagen files for voluntary or involuntary bankruptcy.
If an event of default under the Notes occurs, the holders of the Notes may declare the Notes to be due and payable. An event of default will occur: (a) if Isolagen defaults in the payment of the Notes or any other amounts payable to the holders of the Notes; (b) if Isolagen defaults in the performance of or compliance with any material term contained in the agreements pursuant to which the Notes were issued and such default shall not have been remedied within five business days after written notice to Isolagen; or (c) if Isolagen defaults (as principal or guarantor or other surety) in the payment of any principal of or premium or interest on any

 

10


 

indebtedness for borrowed money, excluding the interest due May 1, 2009 on Isolagen’s pre-existing subordinated notes. The default rate of interest shall be 25% per annum from the date of any event of default under the Notes.
Isolagen is required to redeem the Notes with a 25% premium on the then outstanding principal plus accrued but unpaid interest, upon the (i) receipt of proceeds from the sale of any assets of Isolagen or any of its subsidiaries, excluding sales in the ordinary course of business by Agera Laboratories, Inc.; (b) receipt of the proceeds from any insurance policy held by Isolagen or any of its subsidiaries or pursuant to which Isolagen or any of its subsidiaries are beneficiaries; and (c) receipt of proceeds from the sale of any equity of Isolagen or its subsidiaries or issuance of any indebtedness of Isolagen or any of its subsidiaries. To secure the repayment of the Notes, Isolagen granted the holders of the Notes a security interest in and a lien on the Company’s 57% equity interest in Agera.
C. Equity Interests
As of May 12, 2009, Isolagen had 42,820,380 common stock shares issued, and 38,820,380 common stock shares outstanding. Further, there were approximately 8,117,000 stock options outstanding. There were also approximately 8,646,000 shares of contingently issuable common shares outstanding related to Isolagen’s $79.2 million of convertible debt (convertible at a common share price equivalent to approximately $9.16). Isolagen also has preferred stock authorized, none of which is issued and outstanding.
D. Events Leading to Bankruptcy
The Debtors have incurred losses since their inception, have never generated significant revenue from commercial sales of their products, and have never been profitable. The Debtors are focused on product development, and has expended significant resources on its clinical trials, personnel and research and development. The Company’s consolidated net losses for the years ended 2008 and 2007 were $31.4 million and $35.6 million, respectively. As of December 31, 2008, the Company had an accumulated development stage net loss attributable to common shareholders of $194.1 million. The Company previously failed its Phase III wrinkle trials in 2005. As a result of this failure, the Company’s $90 million of convertible debt did not convert into equity. Further, the Company utilized its remaining cash resources at the time, which were originally planned to be utilized for a commercial launch had the Phase III trials been successful and approved by the FDA, to re-design and re-perform the Phase III trials. The Company successfully completed the re-performed Phase III trials in late 2008 under a new management team, however, due to the remaining cash position of the Debtors and the $90 million of debt due as early as November 2009, and further compounded by unprecedented economic downturns with respect to the equity and credit markets, the Debtors are now in an untenable financial position.
Isolagen did not make an interest payment of approximately $1.5 million that was due on May 1, 2009 to the holders of $79.24 million in principal amount of subordinated notes and is now in default. Isolagen does not have the cash or available resources to pay the $1.5 million of interest which was due.

 

11


 

Consequently, on June 15, 2009, the Debtors filed for protection under chapter 11 of the Bankruptcy Code to obtain financing and to restructure its current debt structure so that it may continue its product development.
III. THE CHAPTER 11 CASES
On June 15, 2009, (the “Petition Date”), the Debtors each filed a voluntary petition for relief under chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. The Debtors cases are being jointly administered. Please refer to the docket in these Cases for the specific relief granted upon the commencement of these Cases.
Contemporaneously with the filing of the voluntary petitions, the Debtors filed the Restructuring Agreement as Exhibit A to the Declaration of Declan Daly in Support of First Day Motions and Applications. The Restructuring Agreement sets forth the key terms of the Plan agreed upon by the Debtors, Viriathus, and the Participating Holders, which include, Ronald Phillips, Morgan Stanley & Co., Incorporated, Credit Suisse Securities (USA) LLC, Highbridge International, LLC, Akanthos Capital Management LLC, CSS, LLC, Alexandra Global Master Fund Ltd, and Context Advantage Master Fund, L.P. The Restructuring Agreement was negotiated and executed prior to the Petition Date and provides for (a) the deadline for plan solicitation, (b) the treatment of classified and unclassified claims and interests under the Plan, (c) corporate governance post-confirmation, and (d) the terms of the Exit Financing. Generally, the Restructuring Agreement provides for a debt to equity swap. The terms of the Restructuring Agreement represent a heavily-negotiated settlement with the key constituents in these Cases. It was negotiated to attempt provide a recovery to interested parties in these Cases. Absent the compromise set forth in the Restructuring Agreement, the Debtors only alternative would have been to file petitions under chapter 7 of the Bankruptcy Code and to liquidate. The Debtors believe that creditors would be extremely unlikely to receive a Distribution if their assets are liquidated in a chapter 7 cases.
On June 17, 2009, the Bankruptcy Court authorized the Debtors, on an interim basis, to borrow up to $1 million from the DIP Lenders. Upon entry of a final order approving debtor-in-possession financing, the Debtors may borrow up to $2.75 million subject to further increase in the discretion of the DIP Lender to fund the 11-week budget proposed by the Debtors. A final hearing on the Debtors’ request for debtor-in-possession financing is scheduled for July 6, 2009 at 10:30 a.m.
IV. SUMMARY OF THE PLAN
The following is a brief summary of the key provisions of the Plan. Holders of Claims and Interests should refer to the Plan for a more detailed description of the terms thereof.
A. General Framework of the Plan
The purpose of the Plan is to restructure the Debtors’ outstanding indebtedness and equity and resolve the Debtors’ liquidity problems, thereby enhancing the recoveries for the Debtors’ creditors and enabling the Debtors to continue as a going concern and properly focus upon development of their product technology in light of ongoing clinical trial developments in order to develop a licensed, marketable product.

 

12


 

As is set forth more fully below and in the Plan, the Holders of the Allowed DIP Facility Claims have agreed that, in lieu of accepting Cash on account of their Allowed DIP Lender Claims, the DIP Lenders shall receive, together with the Pre-Petition Lenders, their Pro Rata share of up to 61% of the New Common Stock of the reorganized Isolagen debtor, Renuvagen, subject to dilution by the Exit Financing. The DIP Lenders and the Pre-Petition Lenders have also agreed to compensate Viriathus or its assignee 10% of its Pro Rata Distribution of the New Common Stock. To date, the DIP Lenders and Pre-Petition Lenders have not entered into any agreements or reached any understandings with any party other than the Agent, DIP Lender and/or Prepetition Lender with regard to the transfer or other disposition of the New Common Stock that they will receive under this Plan. Following the Effective Date of the Plan, the DIP Lenders and Pre-Petition Lenders may, in their sole and absolute discretion, transfer or otherwise dispose of their shares of New Common Stock.
The Holders of Allowed Other Secured Claims are not impaired and will be paid in full under the Plan, and each Holder of Allowed Claims arising from or relating to the 3.5% Convertible Notes shall each receive its Pro Rata share of an unsecured note in the principal amount of $6 million (the “New Note”) and its Pro Rata share of 33% of the New Common Stock subject to dilution by the Exit Financing.
To facilitate treatment to the Debtors’ general unsecured creditors, whose purported Claims total approximately $1,075,000, the Debtors propose to pay Each Holder of an Allowed General Unsecured Claim, in full and final satisfaction, settlement, release and discharge of and in exchange for such Allowed General Unsecured Claim, their Pro Rata portion of 1% of the New Common Stock, subject to dilution by the Exit Financing.
Finally, no distributions shall be made under the Plan on account of the Old Common Stock and the Intercompany Claims, and any and all liability on account of such Old Common Stock and Intercompany Claims shall be deemed discharged. The Debtors will seek a determination from the Bankruptcy Court that the issuance of the New Common Stock under this Plan shall be exempt from registration under the Securities Act and any state or local law, pursuant to section 1145 of the Bankruptcy Code.
B. Distributions under the Plan
As required by Section 1122 of the Bankruptcy Code, the Plan divides all Claims (other than Administrative Expense Claims, Priority Claims, and DIP Facility Claims) and Interests into separate Classes, based on the similarity of the Holders’ legal rights. The following chart summarizes the proposed distributions to Holders of Claims and Interests under the Plan, as well as the Debtor’s estimate of the value of such recoveries. The information provided herein is solely for ease of reference, and parties should consult the terms of the Plan for specific treatment of each class of Claims and Interests.

 

13


 

         
Class   Treatment if Allowed   Estimated Recovery
1— Pre-Petition Lender Claims impaired
  Subject to and pursuant to the terms of the Plan, the Holders of the Allowed Pre-Petition Lender Claims have agreed that, in lieu of accepting Cash on account of their Allowed Pre-Petition Lender Claims, the Pre-Petition Lenders shall receive, together with the DIP Lenders as set forth in Section 3.06 of the Plan, their Pro Rata share of up to 61% of the New Common Stock of Renuvagen, subject to dilution by the Exit Financing.   Satisfied under New
Common Stock
 
       
2—Other Secured Unimpaired
  On the Distribution Date, each Holder of an Allowed Class 2 Claim shall receive in full satisfaction, settlement, release and discharge of and in exchange for such Allowed Other Secured Claim and at Debtors’ exclusive election, either: (i) Cash equal to the amount of such Allowed Other Secured Claim, or (ii) the Collateral which serves as security for such Allowed Other Secured Claim, except to the extent that any Holder of an Allowed Other Secured Claim agrees to less favorable treatment thereof. Upon receipt of the Distribution provided for herein, each Holder of an Allowed Other Secured Claim shall irrevocably release and discharge any and all Liens against the Debtors’ property and Assets.   100%
 
       
3—3.5% Unsecured Convertible Notes impaired
  Each Holder of an Allowed 3.5% Noteholder Claim shall receive, in full and final satisfaction, settlement, release and discharge of and in exchange for such Allowed 3.5% Noteholder Claim the following:   Satisfaction under New Common Stock and New Note
 
       
 
  (a) its Pro Rata share of an unsecured note in the principal amount of $6 million (the “New Note”). The New Note shall have the following features:    
 
       
 
 
1. Type of Security: Unsecured Debentures
   
 
       
 
 
2. Interest: 12.5% payable quarterly in Cash or, at the Reorganized Debtors’ option, 15% payable in kind (“PIK”) by capitalizing such unpaid amount and adding it to the principal as of the date it was due.
   
 
       
 
 
3. Maturity Date: June 1, 2012
   
 
       
 
 
4. Redemption Rights: At any time prior to the maturity date, the Reorganized Debtors may redeem any portion of the outstanding principal of the New Notes in Cash at 125% of the stated face value of the New Notes.
   
 
       
 
 
5. Mandatory Redemption: The Reorganized
   

 

14


 

         
Class   Treatment if Allowed   Estimated Recovery
 
 
Debtors will be obligated to redeem all outstanding New Notes upon the following events:
   
 
       
 
 
a) The Reorganized Debtors successfully complete a capital campaign raising in excess of $10,000,000; or
   
 
       
 
 
b) The Reorganized Debtors are acquired by, or sell a majority stake to, an outside party.
   
 
       
 
  Negative Covenants: The New Notes shall contain customary representations, warranties and covenants, including a covenant that the Reorganized Debtors shall be prohibited from the incurrence of additional debt without obtaining the consent of 66 2 / 3 % of the New Note holders.    
 
       
 
  (b.) its Pro Rata share of 33% of the New Common Stock subject to dilution by the Exit Financing.    
 
       
 
  (c.) The Plan allows the 3.5% Noteholder Claims in the amount of the outstanding principal and accrued and unpaid interest as of the Petition Date in the approximate aggregate amount of $81 million (plus any other amounts due under the indenture and allowable under the Bankruptcy Code).    
 
       
4—General Unsecured Claims Impaired
  Each holder of an Allowed General Unsecured Claim shall, in full and final satisfaction, settlement, release and discharge of and in exchange for such Allowed General Unsecured Claim, be paid their Pro Rata portion of 1% of the New Common Stock, subject to dilution by the Exit Financing.   Satisfaction under
New Common Stock
 
       
5—Old Common Stock impaired
  On the Effective Date, all Interests in Old Common Stock shall be cancelled and extinguished under the Plan and Holders thereof shall neither retain nor receive any distribution of property or Assets on account of their Interests.   0%
 
       
6—Intercompany Claims impaired
  No distributions shall be made under the Plan on account of Intercompany Claims, and any and all liability on account of such Intercompany Claims shall be deemed discharged.   0%
Under a chapter 11 plan, the separate classes of claims and equity interests must be designated either as “impaired” or “unimpaired” by the plan. If a class of claims is “impaired,” the Bankruptcy Code affords certain rights to the holders of such claims, such as the right to vote on the plan (unless the plan provides for no distribution to the holders, in which case, the holder is deemed to reject the plan), and the right to receive under the Chapter 11 plan property of a value that is not less than the value the holder would receive if the debtors were liquidated under Chapter 7.

 

15


 

Under Section 1124 of the Bankruptcy Code, a class of claims or interests is “impaired” unless the plan (i) does not alter the legal, equitable, or contractual rights of the holders or (ii) irrespective of the holders’ acceleration rights, cures all defaults (other than those arising from the debtor’s insolvency, the commencement of the case, or nonperformance of a non-monetary obligation), reinstates the maturity of the claims or interests in the class, compensates the holders for actual damages incurred as a result of their reasonable reliance upon any acceleration rights, and does not otherwise alter their legal, equitable, or contractual rights. Typically, this means the holder of an unimpaired claim will receive on the later of the effective date or the date on which amounts owing are due and payable, payment in full, in cash, with post-petition interest to the extent appropriate and provided under the governing agreement (or if there is no agreement, under applicable non-bankruptcy law), and the remainder of the debtors’ obligations, if any, will be performed as they come due in accordance with their terms. Thus, other than its right to accelerate the debtor’s obligations, the holder of an unimpaired claim will be placed in the position it would have been in had the debtor’s case not been commenced.
The Plan has classified all Claims and Interests in compliance with the provisions of Section 1122 of the Bankruptcy Code, but it is possible that a Holder of a Claim or Interest may challenge the classification of Claims and Interests and that the Bankruptcy Court may find that a different classification is required for the Plan to be confirmed. In such event, the Debtors intend, to the extent permitted by the Bankruptcy Court and the Plan, to make such reasonable modifications of the classifications under the Plan to permit confirmation and to use the Plan acceptances received in this solicitation for the purpose of obtaining the approval of the reconstituted Class or Classes of which the accepting Holder is ultimately deemed to be a member. Any such reclassification could adversely affect the Class in which such Holder was initially a member, or any other Class under the Plan, by changing the composition of such Class and the vote required of that Class for approval of the Plan. Furthermore, a reclassification of a Claim or Interest after solicitation of acceptances of the Plan could necessitate a re-solicitation of acceptances of the Plan.
C. Administrative Expense Claims, Priority Tax Claims, Priority Non-Tax Claims, and DIP Facility Claims
The Bankruptcy Code does not require classification of certain priority claims against a debtor. In these chapter 11 Cases, these unclassified claims include Administrative Expense Claims, Priority Tax Claims, Priority Non-Tax Claims, and DIP Facility Claims. Each of these Claims will receive the treatment set forth in the Plan, which is also set forth below.
Administrative Expense Claims are not impaired under the Plan. Each Holder of an Allowed Administrative Expense Claim, shall, in full and final satisfaction, release and discharge of and in exchange for such Allowed Administrative Expense Claim, be paid either (i) in Cash, in the amount of the Allowed Administrative Expense Claim on the later of (x) the Effective Date or as soon thereafter as is reasonably practicable and (y) the date such Allowed Administrative Expense Claim becomes Allowed, or due and payable in the ordinary course of business or (ii) on such other terms and conditions as may be agreed upon between the Holder of the Allowed Administrative Expense Claim, the Debtors, and Viriathus.

 

16


 

Priority Non-Tax Claims are not impaired under the Plan. Each Holder of an Allowed Priority Non-Tax Claim shall, in full and final satisfaction, settlement, release and discharge of and in exchange for such Allowed Priority Non-Tax Claim, receive Cash in the amount of the Allowed Priority Non-Tax Claim, except to the extent that any Holder of an Allowed Priority Non-Tax Claim agrees to less favorable treatment thereof, on the later of (x) the Effective Date or as soon thereafter as is reasonably practicable and (y) the date such Allowed Administrative Expense Claim becomes Allowed.
Priority Tax Claims are not impaired under the Plan. Each Holder of an Allowed Priority Tax Claim shall, in full and final satisfaction, settlement, release and discharge of and in exchange for such Allowed Priority Tax Claim, be paid in full through deferred Cash payments in an aggregate principal amount equal to the amount of the Allowed Priority Tax Claim plus interest on the unpaid portion at the rate of 4% per annum from the Effective Date through the date of payment thereof which may be as long as 5 years from the order for relief in these Cases, except to the extent that any Holder of an Allowed Priority Tax Claim agrees to less favorable treatment thereof.
Pursuant to Section 1129(a)(9)(A) of the Bankruptcy Code, each Holder of an Allowed DIP Facility Claim is entitled to receive in full satisfaction, settlement, release and discharge of and in exchange for such Allowed DIP Facility Claim, Cash equal to the Allowed amount of such Claim, except to the extent that such Holder of a particular DIP Facility Claim has agreed to less favorable treatment of such claim. Under the Plan, and pursuant to the settlements and compromises set forth therein, the DIP Facility Claims shall be Allowed in the DIP Facility Maximum Repayment. Subject to and pursuant to the terms of the Plan, the Holders of the Allowed DIP Facility Claims have agreed that, in lieu of accepting Cash on account of their Allowed DIP Lender Claims, the DIP Lenders shall receive, together with the Pre-Petition Lenders as set forth in Section 4.01 of the Plan, their Pro Rata share of up to 61% of the New Common Stock of Renuvagen, subject to dilution by the Exit Financing.
D. Exit Financing
On the Effective Date, the Reorganized Debtors may issue New Common Stock in Renuvagen to the Plan Funders in exchange for $2 million to fund the Reorganized Debtors’ continued operations and the distributions that the Reorganized Debtors must make pursuant to the terms of this Plan. This New Common Stock will be issued at 1 1 / 2 times the DIP Facility conversion valuation on Schedule A included in the Plan Supplement.
Rights of participation as a Plan Funder shall be extended the DIP Lenders, the Pre-Petition Lenders, and the 3.5% Convertible Noteholders in the amount of $2,000,000.00. A right to participate in future financings of the Reorganized Debtors (other than with respect to (x) issuances pursuant to option or employee plans (y) the sale of equity or equity-linked securities by the Reorganized Debtors pursuant to a bona fide , firm underwriting public offering, or (z) the issuance of equity or equity-linked securities by the Reorganized Debtors in connection with a bona fide strategic alliance, so long as the equity being offered does not exceed 5% of the equity on a fully-diluted basis immediately prior to such issuance) are extended to (i) the 3.5%

 

17


 

Convertible Noteholders, (ii) the Pre-petition Lenders, and (iii) the DIP Lenders (collectively, the “Covered Investors”) such that, for any equity or equity-linked capital raise done by the Reorganized Debtors, the Covered Investors will have the right to invest in such raise up to an amount that would allow them to preserve their existing equity ownership stake on a fully-diluted basis.
E. Management Incentive Plan
The management team of the Reorganized Debtors and their subsidiaries shall receive 5% of the New Common Stock, subject to dilution by the Exit Financing. The management team’s equity state shall be subject to a two-year vesting schedule whereby 50% shall vest on the Effective Date, 25% shall vest on the first anniversary, and 25% shall vest on the second anniversary. The management incentive plan shall be subject to documentation in a form acceptable to the management team and binding upon the Reorganized Debtor on the Effective Date, with such documentation provided on, or prior to, the deadline for submission of the Plan Supplement; provided, however, that the management incentive plan need not be filed with the Bankruptcy Court.
F. Permanent Injunction, Release & Exculpation
The Plan provides for the release of claims by parties in interest in these cases and the release of other claims and causes of action. Each Holder of a Claim or Interest should review and consider the terms and conditions of Section 10 of the Plan. If the Plan is confirmed, the applicable parties in interest will be bound by the releases and injunctions set forth in the Plan. In order to give notice to all parties of these provisions, the releases and injunctions set forth in the Plan are reprinted below:
I. Discharge of Claims:
As of the Effective Date, except as provided in the Confirmation Order or otherwise provided herein, the rights afforded under this Plan and treatment of Claims and Old Common Stock under the Plan shall be in exchange for and complete satisfaction, discharge and release of all Claims from the beginning of time through the Effective Date. Except as otherwise provided in the Plan, or the Confirmation Order, Confirmation shall, as of the Effective Date, discharge the Debtors from all Claims or other debts that arose before the Effective Date, including, but not limited to, all debts of the kind specified in Bankruptcy Code Sections 502(g), 502(h) or 502(i), whether or not (i) a proof of claim based on such debt is filed or deemed filed pursuant to Bankruptcy Code Section 501, or (ii) a Claim based on such debt is Allowed pursuant to Bankruptcy Code Section 402, or (iii) the Holder of a Claim based on such debt has accepted the Plan. As of the Effective Date, except as otherwise provided in the Plan, or the Confirmation Order, all Entities shall be precluded from asserting against the Debtors or Reorganized Debtors, or their respective successors or property, any other or further Claims, demands, debts, rights, causes of action, liabilities or equity interests based upon any act, omission, transaction or other activity of any kind or nature that occurred prior to the Effective Date. In accordance with the foregoing, except as provided in this Plan, or Confirmation Order, the Confirmation Order shall be a judicial determination, as of the Effective Date pursuant to Bankruptcy Code Sections 524 and 1141, of discharge of all such Claims against the Debtors and such discharge shall void any

 

18


 

judgment obtained against the Debtors or the Reorganized Debtors at any time, to the extent that such judgment relates to a discharged Claim.
II. Injunction:
Except as otherwise set forth in this Plan, on and after the Effective Date, all persons and entities that have held, hold, or may hold (a) any Claim against, or Interest in, the Debtors which arose prior to the Effective Date shall be permanently enjoined from and against: (i) commencing or continuing in any manner any suit, action or other proceeding of any kind against the Debtors, the Reorganized Debtors, their respective affiliates, shareholders, accountants, direct or indirect subsidiaries, agents, attorneys, advisors, (and with regard to all of the foregoing entities, their officers and directors), and/or the estates (collectively, the “Permanent Injunction Parties”) with respect to any such Claim or Interest; (ii) the enforcement, attachment, collection, or recovery by any manner or means of any judgment, award, decree, or order against the permanent injunction parties; (iii) creating, perfecting or enforcing any lien or encumbrance of any kind against the permanent injunction parties or against any of their properties or interests in property with respect to such Claim or Interest; and (iv) asserting any right of setoff against any obligation due from the permanent injunction parties or against any property or interest in property of the Debtors or the Reorganized Debtors with respect to any such Claim or Interest; and (b) any Claim, right, action, cause of action against or Interest in the Debtors, the Reorganized Debtors, or the Estates which shall have arisen prior to the confirmation date shall be permanently enjoined from and against commencing or continuing any suit, action, or proceeding against, asserting or attempting to recover any claim against or interest in, or otherwise affecting the permanent injunction parties with respect to any matter that is the subject of this plan.
III. Exculpation and Limitation of Liability:
None of the Debtors, the Agent, the Pre-Petition Lenders, the DIP Lenders or the Plan Funders or any of the respective shareholders, members, officers, directors, employees, agents, attorneys, consultants, lenders, investment bankers, accountants and affiliates (and each of their respective shareholders, members, officers, directors, employees, agents, attorneys, consultants, lenders, investment bankers, accountants and affiliates of the foregoing, in their respective capacities as such) shall have or incur any liability to any Holder of a Claim or Old Common Stock for any act or omission in connection with, related to, or arising out of, the Cases, the pursuit of confirmation of the Plan, the consummation of the Plan or the administration of the Plan or the property to be distributed under the Plan except for willful misconduct or gross negligence, and, in all respects, the Debtors, the Agent, the DIP Lenders, the Pre-Petition Lenders and the Plan Funders shall be entitled to rely upon the advice of counsel with respect to their duties and responsibilities under the Plan.
IV. Releases:
(a) Compromise of Controversies. Pursuant to Bankruptcy Rule 9019, and in consideration for the classification, distribution and other benefits provided under the Plan, the provisions of the Plan shall constitute a good faith compromise and settlement of all Claims, Interests and controversies resolved pursuant to the Plan, including, without limitation, all Claims and Interests arising prior to the Petition Date, whether known or unknown, foreseen or

 

19


 

unforeseen, asserted or unasserted, by or against the Debtors, the Agent, the DIP Lenders, the Pre-Petition Lenders and the Plan Funders, arising out of, relating to or in connection with the business or affairs of or transactions with the Debtors. The entry of the Confirmation Order shall constitute the Bankruptcy Court’s approval of each of the foregoing compromises or settlements, and all other compromises and settlements provided for in the Plan, and the Bankruptcy Court’s findings shall constitute its determination that such compromises and settlements are in the best interests of the Debtors, the Estates, creditors, equity holders, and other parties in interest, and are fair, equitable and within the range of reasonableness. The provisions of the Plan, including, without limitation, its release, injunction, exculpation and compromise provisions, are mutually dependent and non-severable. If the Plan is confirmed, the applicable parties in interest will be bound by the releases and injunctions set forth in the Plan.
(b) Releases by the Debtors. As of the Effective Date, the Debtors and their estates hereby waive, release and discharge (i) the DIP Lender, (ii) the Pre-Petition Lenders; (iii) the Agent, (iv) the Plan Funders and (v) the Debtors’ present and former officers and directors, and (iv) each of the respective shareholders, members, officers, directors, employees, agents, attorneys, consultants, lenders, investment bankers, accountants and affiliates in their respective capacities as such of the parties released in clauses (i), (ii), and (iii) of this Section, from any Claim, obligation, right, Cause of Action or liability, whether known or unknown, foreseen or unforeseen, existing or hereafter arising, based in whole or in part on any act or omission, transaction or occurrence from the beginning of time through the Effective Date in any way relating to the Debtors, the Cases or the Plan.
(c) Releases by Holders of Claims or Interests. On the Effective Date, the Debtors, the Reorganized Debtors, the Agent, DIP Lender, the Pre-Petition Lenders and the Plan Funders and their respective affiliates, direct or indirect subsidiaries—along with the present and former officers, directors, agents, shareholders, attorneys, accountants, the estates, and advisors of each of the foregoing (the “Released Parties”) will automatically be released from all Claims and Causes of Action of every kind and nature, from the beginning of time through the Effective Date for all acts and omissions occurring both before and after the Petition Date, whether known or unknown, that may be asserted by: (i) the Released Parties; (ii) any Holder of a Claim or Interest in Classes 1, 2, 3, 4, and 6; (iii) Holders of Priority Claims and Holders of Administrative Expense Claims; (iv) the Agent; and (v) the DIP Lenders that in any way relate to, or arise in connection with, the Debtors, the Reorganized Debtors, or these Cases—including, without limitation, the Debtors’ present and former businesses, operations, or financing. The release provisions set forth in this section shall act as an injunction against any entity commencing or continuing any action, employment of process, or act to collect, offset, or recover any Claim or Causes of Action satisfied, released, or discharged under this Plan. This injunction (the “Injunction”) shall apply regardless of whether a Proof of Claim or interest based on such Claim, debt, liability, or Interest is filed or allowed, or whether such entity voted to accept or reject this Plan except for parties in Classes 1, 3, and 4 who submit a ballot indicating that they opt out of this release. Without in any way limiting the foregoing, all Injunctions or stays entered in these Cases and existing immediately prior to the Confirmation Date shall remain in full force and effect until the Effective Date. This release in this subsection binds all parties in interest except for: (i) parties in Classes 1, 3, and 4 who submit a ballot indicating that they opt out of this release, and (ii) Holders of Interests in Class 5.

 

20


 

The foregoing release shall not apply to any duties, obligations, responsibilities, claims or causes of action that in any way relate to, or arise in connection with the Exit Facility.
V. Injunction Related to Releases and Exculpation:
The Confirmation Order will permanently enjoin the commencement or prosecution by any person or entity, whether directly, derivatively or otherwise, of any claims, obligations, suits, judgments, damages, debts, rights, causes of action or liabilities released pursuant to this Plan, including, but not limited to the claims, obligations, suits judgments, damages, demands, debts, rights, causes of action or liabilities released in Article 10 of this Plan.
***
The terms of the Restructuring Agreement, which form the terms of the Plan, represent a heavily-negotiated settlement with the key constituents in these Cases. It was negotiated to attempt to provide a recovery to interested parties in these Cases. Absent the compromise set forth in the Restructuring Agreement, which set forth the terms which comprise the Plan, the Debtors only alternative would have been to file petitions under chapter 7 of the Bankruptcy Code and to liquidate. The Debtors believe that creditors would be extremely unlikely to receive a Distribution if their assets are liquidated in a chapter 7 case. Therefore, the Plan is a compromise under Bankruptcy Rule 9019.
G. Bar Date
The Bar Date shall be set by Order of the Bankruptcy Court prior to the Confirmation of the Plan as the Bar Date— i.e. , last date by which any Holder of a Claim or Interest, including Administrative Expense Claims pursuant to section 503(b)(9) of the Bankruptcy Code, can assert Claims against the Debtors arising prior to the Petition Date. If a Claim or Interest is not scheduled or is scheduled as disputed, contingent, or unliquidated, the Holder of such claim or interest shall file with this Court a Proof of Claim or Interest (as applicable) or a motion for allowance of an Administrative Claim. All requests for allowance of an Administrative Claim shall be made by Motion to this Court.
Any motions for allowance of an Administrative Expense Claims not arising under section 503(b)(9) of the Bankruptcy Code and not constituting Professional Fees shall be filed by the later of: (i) 30 days after such Claim is incurred, or (ii) 30 days after the Confirmation Date. Service of the Confirmation Order shall constitute reasonable and adequate notice of the Bar Date for Administrative Expense Claims not arising under section 503(b)(9) of the Bankruptcy Code. After the Bar Date, all parties and Entities who fail to file a proof of claim or interest (as applicable) or a motion for allowance of an Administrative Claim shall not be treated as a creditor with respect to such claim or interest (or Administrative Expense Claim) for the purposes of voting and distribution.
After the Bar Date, all parties and entities shall be permanently enjoined from asserting any Claim against, or Interests in, the Debtors, or the Estates, absent further Order of this Court.

 

21


 

H. Executory Contracts
The Reorganized Debtors shall identify any Executory Contracts to be assumed as of the Effective Date and the amount of cure payments to be provided by Reorganized Debtors in accordance with Bankruptcy Code section 365(b)(1) prior to approval of the Disclosure Statement. Objections to any proposed cure payment must be made by the Voting Deadline and shall be determined, if necessary, at the Confirmation Hearing. A party to an assumed Executory Contract that has not filed an appropriate pleading with the Bankruptcy Court on or before the objection deadline set by the Bankruptcy Court shall be deemed to have waived its right to dispute such amount. The Debtors and the Reorganized Debtors reserve the right to reject any Executory Contract that is listed by the Debtors as an Executory Contract to be assumed. All unpaid cure payments under any Executory Contracts that are assumed or under the Plan shall be made by Reorganized Debtors as soon as practicable after the Effective Date, provided , that, in the event that there is a dispute regarding the amount of any cure payments, the Reorganized Debtors shall make such cure payments as may be required by Bankruptcy Code Section 365(b)(1) within ten (10) days following the entry of a Final Order resolving such dispute.
Each Executory Contract of the Debtors that has not expired by its own terms prior to the Effective Date, that has not been assumed or rejected during these chapter 11 Cases prior to the Effective Date, and is not listed by the Debtors as a Executory Contract to be assumed or is not included in a motion to reject such Executory Contract prior to the Effective Date, shall be deemed rejected by the Debtors pursuant to Bankruptcy Code Section 365 on the Effective Date.
All proofs of claim with respect to Claims arising from the rejection of Executory Contracts shall be filed with the Bankruptcy Court on or before the date established as the last date therefor by the Bar Date Order or other order of the Bankruptcy Court. Any proof of claim that is not timely-filed shall be released, discharged and forever barred from assertion against the Debtors, or their Assets, or Reorganized Debtors.
I. Consolidation for Distribution and Voting Purposes
On the Effective Date, the Estate of each of the Debtors shall be deemed consolidated with each other such that the assets and liabilities of each of the Debtors shall be merged solely for the purposes of Distribution, voting and Confirmation of the Plan. As a consequence, any guaranties by one of the Debtors of the obligations of the other or any joint obligations shall be deemed liquidated so that the Holder of such Claims shall have one Claim against the consolidated Debtors and shall be deemed to be a single obligation. Additionally, each and every proof of claim filed or to be filed in either case shall be deemed filed against the consolidated Estate. Notwithstanding the foregoing, the deemed consolidation of the Estate shall not affect the legal and organizational structure of the Debtors.
V. CONFIRMATION AND CONSUMMATION OF THE PLAN
Under the Bankruptcy Code, the following steps must be taken to confirm and implement the Plan.

 

22


 

A. The Confirmation Hearing
The Bankruptcy Code requires the Bankruptcy Court, after notice, to hold a confirmation hearing. The Confirmation Hearing in respect of the Plan has been scheduled for August 27, 2009 at 2:00 p.m. (Prevailing Eastern Time), before the Honorable Mary F. Walrath, United States Bankruptcy Judge at the United States Bankruptcy Court, 824 Market Street, Fifth Floor, Courtroom Four, Wilmington, Delaware 19801.
B. Confirmation of the Plan
At the Confirmation Hearing, the Bankruptcy Court will confirm the Plan only if all of the requirements of Section 1129 of the Bankruptcy Code are met. These requirements are briefly summarized below.
1. Compliance with the Bankruptcy Code (Sections  1129(a)(1) and 1129 (a)(2))
The Debtors believe that the Plan complies with all the relevant provisions of the Bankruptcy Code and that they have complied with the requirements of the Bankruptcy Code in proposing the Plan.
2. Good Faith (Section  1129(a)(3) )
The Debtors have proposed the Plan in good faith and not by any means forbidden by law. At the Confirmation Hearing, the Debtors will present evidence of their good faith.
3. Court Approval of Payments (Section  1129(a)(4) )
The Plan provides for obtaining the Bankruptcy Court’s approval of any payment made or to be made by the Debtors for services or for costs and expenses in or in connection with these Cases, or in connection with the Plan and incident to these Cases.
4. Disclosure of Directors and Officers (Section  1129(a)(5) )
Pursuant to Bankruptcy Code Section 1129(a)(5), the Debtors will disclose, as part of its plan supplement, the identity and affiliations of any other person proposed to serve on the initial board of directors of Reorganized Debtors, and, to the extent such person is an insider other than by virtue of being a director, the nature of any compensation for such person. The classification and composition of the board of Reorganized Debtors shall be consistent with the New Articles of Incorporation. The Debtors assert that the appointment of such individuals will be consistent with the interests of the Debtors’ Claims and Interest Holders and with public policy.
5. Approval of Rate Change (Section  1129(a)(6) )
Section 1129(a)(6) of the Bankruptcy Code does not apply to the Debtors.
6. Best Interests Test (Section  1129(a)(7) )
With respect to each impaired Class of Claims and Interests, the Bankruptcy Code requires that in order for the Plan to be confirmed, each Holder of a Claim or Interest either (a)

 

23


 

accept the Plan; or (b) receive or retain under the Plan property of a value, as of the Effective Date, that is not less than the value such holder would receive or retain if the Debtors were liquidated under chapter 7 of the Bankruptcy Code. To determine what Holders of Claims and Interests of each impaired Class would receive if the Debtors were liquidated under chapter 7, the Bankruptcy Court must determine the dollar amount that would be generated from the liquidation of the Debtors’ Assets and properties in the context of a chapter 7 liquidation case. The cash amount that would be available for satisfaction of unsecured non-priority Claims and Interests would consist of the proceeds resulting from the disposition of the unencumbered assets and properties of the Debtor, augmented by the unencumbered cash held by the Debtors at the time of the commencement of the liquidation case and litigation recoveries, if any. Such cash amount would be reduced by the amount of the costs and expenses of the liquidation and by such additional administrative and priority claims that might result from the termination of the Debtors’ business and the use of chapter 7 for the purposes of liquidation.
The Debtors’ costs of liquidation under chapter 7 would include the fees payable to a trustee in bankruptcy, as well those fees that might be payable to attorneys and other professionals that such a trustee might engage. In addition, Claims would arise by reason of the breach or rejection of obligations incurred and leases and executory contracts assumed or entered into by the Debtor during the pendency of these Cases. The foregoing types of Claims and other Claims that might arise in a liquidation case or result from these pending Cases, including any unpaid expenses incurred by the Debtors during these Cases such as compensation for attorneys, financial advisors, and accountants, would be paid in full from the liquidation proceeds before the balance of those proceeds would be made available to pay pre-petition general unsecured claims.
To determine if the Plan is in the best interests of each impaired class, the present value of the distributions from the proceeds of a liquidation of the Debtors’ unencumbered assets and properties, after subtracting the amounts attributable to the foregoing claims, are then compared with the value of the property offered to such Classes of Claims and Equity Interests under the Plan.
After considering the effects that a chapter 7 liquidation would have on the ultimate proceeds available for distribution to creditors in these Cases, including: (a) the liens asserted in and to the Debtors’ assets by the Pre-Petition Lenders; (b) the increased costs and expenses of a liquidation under chapter 7 arising from fees payable to a trustee in bankruptcy and professional advisors to such trustee; (c) the erosion in value of assets in a chapter 7 case in the context of the expeditious liquidation required under chapter 7 and the “forced sale” atmosphere that would prevail; and (d) the substantial increases in claims which would be satisfied on a priority basis or on parity with creditors in these cases, the Debtors have determined that confirmation of the Plan will provide each Holder of an Allowed Claim or Interest with a recovery that is not less than such Holder would receive pursuant to liquidation of the Debtors under chapter 7.
The Debtors also believe that the value of any distributions to each Class of Allowed Claims in a chapter 7 case, including all Secured Claims and Priority Tax Claims, would be less than the value of distributions under the Plan because such distribution in a chapter 7 case would not occur for a substantial period of time. It is likely that distribution of the proceeds of the liquidation could be delayed for years after the completion of such liquidation to resolve Claims

 

24


 

and prepare for distributions. In the likely event litigation was necessary to resolve Claims asserted in the chapter 7 case, the delay could be prolonged.
The Liquidation Analysis of the Debtors and prepared by the Debtors’ financial advisor is attached as an Exhibit hereto. Underlying the Liquidation Analysis are a number of estimates and assumptions that, although developed and considered reasonable by the Debtors’ financial advisors, are inherently subject to significant economic and competitive uncertainties and contingencies beyond the control of the Debtors. The Liquidation Analysis is also based on assumptions with regard to liquidation decisions that are subject to change. Accordingly, the values reflected might not be realized if the Debtors were, in fact, to undergo such a liquidation.
7. Confirmation of a Consensual Plan (Section  1129(a)(8) )
Section 1129(a)(8) requires that to confirm a consensual Plan, each class must be unimpaired or vote to accept the plan. In these Cases, if each Class does not satisfy this requirement, then the Plan may be confirmed as a non-consensual plan under Sections 1129(a)(10) and 1129(b) as long as the requirements below are satisfied.
8. Treatment of Claims Entitled to Priority (Section  1129(a)(9) )
The Plan provides for the treatment of Administrative Expense Claims and Priority Claims in the manner required by Section 1129(a)(9) of the Bankruptcy Code.
9. Confirmation of a Nonconsensual Plan (Sections  1129(a)(10) and 1129(b) )
In the event that any impaired Class of Claims or Interests does not accept the Plan, the Bankruptcy Court may nevertheless confirm the Plan if all other requirements under Section 1129(a) of the Bankruptcy Code are satisfied, and if, with respect to each impaired Class which has not accepted the Plan, the Bankruptcy Court determines that the Plan does not “discriminate unfairly” and is “fair and equitable” with respect to such Class. Confirmation under Section 1129(b) of the Bankruptcy Code requires that at least one impaired Class of Claims accept the Plan, excluding any acceptance of the Plan by an “insider” (as that term is defined in Section 101 of the Bankruptcy Code). The Debtor intends to seek confirmation of the Plan notwithstanding the non-acceptance of one or more impaired Classes.
The Bankruptcy Code does not define what is meant by “does not discriminate unfairly,” but it is generally interpreted to mean that similarly-situated creditors or interest holders must receive similar consideration under the plan. The Bankruptcy Code provides a non-exclusive definition of the phrase “fair and equitable,” as follows:
Secured Claims
The condition that a plan be “fair and equitable” with respect to a non-accepting class of secured claims includes the requirements that (a) the holders of such secured claims retain the liens securing such claims to the extent of the allowed amount of the claims, whether the property subject to the liens is retained by the debtor or transferred to another entity under the plan and (b) each holder of a secured claim in the class receives deferred cash payments totaling at least the allowed amount of such claim with a present value, as of the effective date of the plan, at least

 

25


 

equivalent to the value of the secured claimant’s interest in the debtor’s property subject to the liens.
Unsecured Claims
The condition that a plan be “fair and equitable” with respect to a non-accepting class of unsecured claims includes the following requirement that either: (i) the plan provides that each holder of a claim of such class receive or retain on account of such claim property of a value, as of the effective date of the plan, equal to the allowed amount of such claim; or (ii) the holder of any claim or interest that is junior to the claims of such class will not receive or retain under the plan on account of such junior claim or interest any property.
Equity Interests
The condition that a plan be “fair and equitable” with respect to a non-accepting class of equity interests includes the requirements that either: (a) the plan provide that each holder of an equity interest in such class receive or retain under the plan, on account of such equity interest, property of a value, as of the effective date of the plan, equal to the greater of (i) the allowed amount of any fixed liquidation preference to which such holder is entitled; (ii) any fixed redemption price to which such holder is entitled; or (iii) the value of such interest; or (b) if the class does not receive such an amount as required under (a), no class of equity interests junior to the non-accepting class may receive a distribution under the plan.
The Debtors believe that the Plan would not discriminate unfairly against, and is fair and equitable with respect to, any non-accepting Class of Claims or Interests.
10. Feasibility (Section  1129(a)(11) )
The Bankruptcy Code permits a plan to be confirmed if the Bankruptcy Court finds that it is not likely to be followed by liquidation or the need for further financial reorganization, unless the plan itself provides for a liquidation. This requirement is the so-called “feasibility test.” The Plan provides that the Reorganized Debtors will emerge with sufficient Cash and Exit Financing to satisfy, in full, all payments required under the Plan. The Debtors will not accept Exit Financing unless it is sufficient to fund ongoing operations and satisfy, in full, all payments required under the Plan. The Reorganized Debtors intend on raising additional funds post-confirmation to assist in the ongoing development of its assets and to pay its bills as they come due. Confirmation of the Plan is a necessary predicate to raising such additional financing and will make such financing more readily accessible given the significant restructuring of the balance sheet and elimination of pre-petition debt. The Debtors therefore believe that the proposed Exit Financing and the expected post-confirmation capital raising will be sufficient for the Debtors to satisfy their obligations under the Plan and to operate their businesses. The Debtors will provide evidence at the Confirmation Hearing that the post-confirmation financing is achievable and will be sufficient to satisfy Section 1129(a)(11).
The Debtors’ businesses successfully completed and re-performed the within-referenced new Phase III trials in late 2008 under a new management team and would like to move forward with the marketing and development of said product technology. As previously described, the Debtors are in the process of seeking approval from the Food and Drug Administration for their

 

26


 

lead product candidate. At present, the Debtors anticipate that this approval will be provided in January 2010, assuming the process progresses at its currently anticipated pace and that no major unanticipated delays are encountered. Upon receiving approval from the FDA, the Debtors will be required to seek substantial funding to allow the Debtors to market its product. Conversely, the Debtors may seek to sell their assets (including the FDA approved technologies) to, or partner with, a party that has the financial wherewithal and industry experience to bring an approved product to market.
11. Payment of Statutory Fees (Section  1129(a)(12) )
All fees payable pursuant to Section 1930 of title 28 of the United States Code in connection with these Cases, as determined by the Bankruptcy Court at the Confirmation Hearing, shall be paid on or before the Effective Date.
12. Retiree Benefits (Section  1129(a)(13) )
Section 1129(a)(13) of the Bankruptcy Code contains certain requirements governing non-pension “retiree benefits” that do not apply to the Debtor.
C. Consummation of the Plan
The Plan will be consummated on the Effective Date. The Effective Date shall be determined and set by the Debtors after the Confirmation Date and shall be a Business Day upon which the conditions precedent to effectiveness of the Plan are satisfied or waived.
VI. RISK FACTORS TO BE CONSIDERED
The Holders of impaired Claims against the Debtors should carefully consider the following factors before deciding whether to vote to accept or reject the Plan.
A. Certain Risks of Non-Confirmation
The Plan sets forth certain conditions precedent to the Bankruptcy Court entering the Confirmation Order, which are as follows:
(a) The Debtors shall have reviewed and updated all financial projections, and such financial projections shall be acceptable in form and substance to Agent and the Debtors, in their sole and absolute discretion.
(b) The Post Petition Credit Agreement shall be in full force and effect without any defaults having occurred that have not been waived by Agent.
(c) The Confirmation Order shall be acceptable in form and substance to the Debtors and the Agent, in their sole and absolute discretion.
(d) The Disclosure Statement Approval Order shall have been entered.
(e) There shall have occurred no Material Adverse Changes.

 

27


 

Even if all of the conditions to confirmation are satisfied, the Plan may not be consummated if any of the conditions precedent to the Effective Date, as are set forth in the Plan, are not met. In addition, the Debtors will emerge from bankruptcy with a need for capital. There is a risk that the anticipated additional funding will not be available to the Debtors, or that there will not be sufficient funding available for the Debtors to obtain the FDA approval set forth above, or that there will not be sufficient funding available for the Debtors to continue to seek the FDA approval set forth above. Based upon the current financial projections that are set forth in the Budget attached hereto as Exhibit D, the Debtors anticipate that the Exit Financing will fund their continued operations for a period of 2-3 months subsequent to the Effective Date of the Plan. As is set forth above, the Debtors believe that after the Effective Date, additional funding may be more readily accessible; for, the Reorganized Debtors will have significantly reduced its liabilities and will possess a much less cumbersome equity structure. However, the Debtors do not currently have firm commitments that any funding will be available to them.
Additionally, even if the required acceptances of each of Class 1, 3, and 4 are received, the Bankruptcy Court might find that the solicitation of votes or the Plan did not comply with the solicitation requirements made applicable by Section 1125 of the Bankruptcy Code. In such an event, the Debtors may seek to re-solicit acceptances, but confirmation of the Plan could be substantially delayed and possibly jeopardized. The Debtors believe that their solicitation of acceptances of the Plan complies with the requirements of Section 1125 of the Bankruptcy Code, that duly executed Ballots and master ballots will be in compliance with applicable provisions of the Bankruptcy Code and the Bankruptcy Rules, and that, if sufficient acceptances are received, the Plan should be confirmed by the Bankruptcy Court.
The Debtors will request that the Bankruptcy Court confirm the Plan under Bankruptcy Code Section 1129(b). Section 1129(b) permits confirmation of the Plan despite rejection by one or more impaired classes if the Bankruptcy Court finds that the Plan “does not discriminate unfairly” and is “fair and equitable” as to the non-accepting class or classes. Classes 5 and 6 are fully impaired and will not receive or retain any property under the Plan. Because Classes 5 and 6 are deemed not to have accepted the Plan, the Debtors will request that the Bankruptcy Court find that the Plan is fair and equitable and does not discriminate unfairly as to such Classes (and any other class that fails to accept the Plan).
Should the Bankruptcy Court fail to confirm the Plan, the Debtors would then consider all financial and other alternatives available to it at that time. Pursuit of any such alternative could result in a protracted and non-orderly reorganization with all the attendant risk of adverse consequences to the Debtors and their ultimate ability to function effectively and competitively.
If the Plan, or a plan determined by the Bankruptcy Court not to require re-solicitation of acceptances by Classes, were not to be confirmed, it is unclear whether a reorganization could be implemented and what Holders of Claims and Interests would ultimately receive with respect to their Claims and Interests. If an alternative reorganization could not be agreed upon, it is possible that the Debtors would have to liquidate assets, in which case Holders of Claims and Interests could receive less than they would have received pursuant to the Plan.

 

28


 

B. Risks of Non-Consummation of Plan
Even if all of the conditions to confirmation are satisfied, the Plan may not be consummated if any of the conditions precedent to the Effective Date, as are set forth in the Plan, are not met. In addition, the Debtors will emerge from bankruptcy with a need for capital. There is a risk that the anticipated additional funding will not be available to the Debtors, or that there will not be sufficient funding available for the Debtors to obtain the FDA approval set forth above, or that there will not be sufficient funding available for the Debtors to continue to seek the FDA approval set forth above. Based upon the current financial projections that are set forth in the Budget attached hereto as Exhibit D, the Debtors anticipate that the Exit Financing will fund their continued operations for a period of 2-3 months subsequent to the Effective Date of the Plan, without regard to the post Effective Date financing which will be sought by the Reorganized Debtors, which the Debtors expect to obtain. As is set forth above, the Debtors believe that after the Effective Date, additional funding will be more readily accessible because the Reorganized Debtors will have significantly reduced its liabilities and will possess a much less cumbersome equity structure. However, the Debtors do not currently have firm commitments that any funding will be available to them.
C. Risks Associated with New Common Stock
The ultimate recoveries under the Plan to holders of Claims against the Debtors depend upon the realizable value of the New Common Stock to be issued under the Plan. The realizable value of the New Common Stock is subject to a number of material risks, including, but not limited to, those specified below. These factors assume that the Plan is approved by the Bankruptcy Court and that all conditions precedent to the Confirmation Date and the Effective Date are satisfied and/or waived pursuant to the Plan.
The New Common Stock will be issued pursuant to the Plan. Some of the recipients may prefer to liquidate their investment rather than hold it on a long term basis. The prices at which the New Common Stock may trade will depend upon a number of factors, including industry conditions, the performance of, and investor expectations for, the Reorganized Debtors, and market factors, such as the number of holders who may wish to dispose of their stock to raise funds or recognize losses for tax purposes or otherwise as well as the projected success of the product technology in future clinical trials.
The Debtor anticipates that dividends may not be paid with respect to the New Common Stock.
THE DEBTORS MAKE NO REPRESENATIONS OR WARRANTIES THAT THE NEW COMMON STOCK WILL BE FULLY TRADEABLE. ALL PARTIES SHOULD DRAW THEIR OWN CONCLUSIONS REGARDING THE TRANSFERABILITY OF THE NEW COMMON STOCK. NOTHING CONTAINED HEREIN SHALL BE INTERPRETED AS AN INDICATION THAT THE NEW COMMON STOCK IS TRADEABLE.

 

29


 

VII. EXEMPTIONS FROM SECURITIES ACT REGISTRATION
A. Generally:
Section 1145 of the Bankruptcy Code creates an exemption from the registration and licensing requirements of the Securities Act of 1933 (the “Securities Act”) and the corresponding provisions of the state securities laws (together with the Securities Act, the “securities laws”) for the issuance and certain resales of the securities issued in connection with a Chapter 11 plan.
B. Initial Issuance of New Common Stock under the Plan
Section 1145(a) of the Bankruptcy Code provides that the securities registration and qualification requirements of the securities laws do not apply to the offer or sale of stock, warrants or other securities by a debtor if the offer or sale occurs under a plan of reorganization and the securities are transferred in exchange (or principally in exchange) for a claim against or interest in the debtor.
THE DEBTORS MAKE NO REPRESENATIONS OR WARRANTIES WITH RESPECT TO SECTION 1145(a) OF THE BANKRUPTCY CODE. THE DEBTORS ARE SEEKING APPROVAL FROM THE BANKRUPTCY COURT OF THE ISSUANCE OF THE NEW COMMON STOCK UNDER EXEMPTIONS FROM REGISTRATION UNDER THE SECURITIES ACT AND ANY STATE OR LOCAL LAW PURSUANT TO SECTION 1145 OF THE BANKRUPTCY CODE; HOWEVER THE DEBTORS CANNOT GUARANTEE THAT SUCH EXEMPTION WILL APPLY OR WILL BE GRANTED. ALL PARTIES SHOULD DRAW THEIR OWN CONCLUSIONS REGARDING THE TRANSFERABILITY OF THE NEW COMMON STOCK AND THE APPLICABILITY OF SECTION 1 145(a) TO THE ISSUANCE OF THE NEW COMMON STOCK. NOTHING CONTAINED HEREIN SHALL BE INTERPRETED AS AN INDICATION THAT THE NEW COMMON STOCK IS TRADEABLE OR EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT AND ANY STATE OR LOCAL LAW PURSUANT TO SECTION 1145 OF THE BANKRUPTCY CODE.
The views of the SEC have not been sought in this particular case and, therefore, the Debtors can give no assurances regarding the current position of the SEC on ordinary trading transactions. The Debtors have not sought any advice from the staff of the SEC with respect to such transactions.
THE DEBTORS HAVE NOT SOUGHT A “NO-ACTION” LETTER FROM THE SEC OR ANY STATE SECURITIES COMMISSION WITH RESPECT TO ANY MATTER DISCUSSED HEREIN.
Section 1145 of the Bankruptcy Code generally exempts from registration the offer or sale of a debtor’s securities of those or an affiliate of, or a successor to, the debtor under a chapter 11 plan if such securities are offered or sold in exchange for a claim against, or interest in, or a claim

 

30


 

for an administrative expense concerning such debtor. The Debtors will seek an Order of the Bankruptcy Court seeking the issuance of the New Common Stock to the Creditors who are entitled to the same under the Plan pursuant to Section 1145(a) of the Bankruptcy Code. Therefore, under Section 1145 of the Bankruptcy Code, the issuance of the New Common Stock and the subsequent resale of such securities by entities that are not “underwriters” (as defined in Section 1145(b) of the Bankruptcy Code, a “Section 1145 Underwriter”) may not be subject to the registration requirements of Section 5 of the Securities Act of 1933, as amended (the “Securities Act”) or equivalent state securities laws. Thus, such shares may be deemed to have been issued in a registered public offering under the Securities Act and, therefore, may be resold by any holder thereof without registration under the Securities Act pursuant to the exemption provided by section 4(1) thereof unless the holder is a Section 1145 Underwriter. In addition, such securities generally may be resold by the recipients thereof without registration under state securities or “blue sky” laws pursuant to various exemptions provided by the respective laws of the several states.
Section 1145(b) of the Bankruptcy Code generally defines “underwriter” for purposes of the Securities Act as one who (a) purchases a claim with a view to distribution of any security to be received in exchange for the claim, (b) offers to sell securities issued under a plan for the holders of such securities, (c) offers to buy securities issued under a plan from persons receiving such securities, if the offer to buy is made with a view to distribution of such securities, (d) is an issuer (in this case, the Reorganized Debtor) of the securities within the meaning of section 2(11) of the Securities Act. The reference contained in Bankruptcy Code §1145(b)(1)(D) to Section 2(11) of the Securities Act includes as Section 1145 Underwriters all persons who, directly or indirectly, through one or more intermediaries, control, are controlled by or are under common control with, an issuer or securities. “Control” (as defined in Rule 405 under the Securities Act) means the possession, direct or indirect, of the power to direct or cause the direction of the policies of a person, whether through ownership of voting securities, by contract, or otherwise. Moreover, the legislative history of Section 1145 of the Bankruptcy Code suggests that a creditor that owns at least ten percent (10%) of the securities of the Reorganized Debtor is a presumptive “control person” of the Reorganized Debtor. To the extent that persons deemed to be “underwriters” receive New Common Stock, resales by such persons would not be exempted by Section 1145 of the Bankruptcy Code from registration under the Securities Act or other applicable law.
Because of the subjective nature of the question of whether a particular holder may be an underwriter, the Debtors make no representations concerning the ability of any person to dispose of the securities to be distributed under the Plan. Each recipient of securities under the Plan should consult its own legal advisor as to whether resales of such recipient’s securities are lawful under federal and state securities laws.
VIII. ALTERNATIVES TO CONFIRMATION AND CONSUMMATION OF THE PLAN
If the Plan is not confirmed and consummated, the alternatives for resolution of the Debtors’ chapter 11 cases include (a) liquidation of the Debtors under chapter 7 or chapter 11 of the Bankruptcy Code, and (b) the preparation and presentation of an alternative plan or plans of reorganization.

 

31


 

A. Liquidation under Chapter 7 or Chapter 11
If no chapter 11 plan can be confirmed, these Cases may be converted to cases under chapter 7 of the Bankruptcy Code in which a trustee would be elected or appointed to liquidate the assets of the Debtors. A discussion of the effect that a chapter 7 liquidation would have on the recovery of holders of Claims and Equity Interests is set forth in Section V.B.6 herein. The Debtors believe that liquidation of the Debtors under chapter 7 would result in (i) smaller distributions being made to creditors than those provided in the Plan because of the additional administrative expenses involved in the appointment of a trustee, and attorneys and other professionals to assist such trustee, (ii) additional expenses and claims, some of which would be entitled to priority, which would be generated during the liquidation and from the rejection of leases and other executory contracts in connection with a cessation of the Debtors’ operations, and (iii) the failure to realize the greater going concern value of the Debtors’ assets.
The Debtors could also be liquidated pursuant to the provisions of a chapter 11 plan of liquidation. In a liquidation under chapter 11, the Debtors’ assets could be sold in a more orderly fashion over a longer period of time than in a liquidation under chapter 7. Thus, chapter 11 liquidation might result in larger recoveries than in a chapter 7 liquidation, but the delay in distributions could result in lower present values received and higher administrative costs. Because a trustee is not required in a chapter 11 case, expenses for professional fees could be lower than in a chapter 7 case, in which a trustee must be appointed. Any distribution to the Holders of Claims under a chapter 11 liquidation plan probably would be delayed substantially. Moreover, the Debtors will likely not have sufficient funds to fund a chapter 11 liquidation. Therefore, a chapter 7 liquidation is more likely if no chapter 11 plan can be confirmed.
B. Alternative Plan of Reorganization
If the Plan is not confirmed, the Debtors or any other party in interest could attempt to formulate a different plan of reorganization. Such a plan might involve either a reorganization and continuation of the Debtors’ businesses or an orderly liquidation of its assets. During the course of preparation of the Plan and prior to filing for relief under chapter 11 of the Bankruptcy Code, the Debtors explored various other alternatives and concluded that the Plan represented the best alternative to protect the interests of Creditors and other parties in interest. The Debtors have not changed their conclusions.
IX. CERTAIN FEDERAL INCOME TAX CONSEQUENCES OF THE PLAN
The following discussion is a summary of certain United States federal income tax consequences of the Plan to the Debtors and to Holders of Claims and Interests. This discussion is based on the Internal Revenue Code of 1986, as amended as of the date hereof (the “Tax Code”), treasury regulations promulgated and proposed thereunder, judicial decisions and published administrative rules and pronouncements of the IRS as in effect on the date hereof. Due to the complexity of certain aspects of the Plan, the lack of applicable legal precedent, the possibility of changes in the law, the differences in the nature of the Claims (including Claims within the same Class) and Interests, the Holders’ status and method of accounting (including Holders within the same Class) and the potential for disputes as to legal and factual matters with the IRS, the tax consequences described herein subject to significant uncertainties. No legal

 

32


 

opinions have been requested from counsel with respect to any of the tax aspects of the Plan, and no rulings have been or will be requested from the IRS with respect to any of the issues discussed below. Furthermore, legislative, judicial or administrative changes may occur, perhaps with retroactive effect, which could affect the accuracy of the statements and conclusions set forth below as well as the tax consequences to the Debtors and the Holders of Claims and Interests.
This discussion does not purport to address all aspects of United States federal income taxation that may be relevant to the Debtors or the Holders of Claims or Equity Interests in light of their personal circumstances, nor does the discussion deal with tax issues with respect to taxpayers subject to special treatment under the United States federal income tax laws (including, for example, banks, governmental authorities or agencies, pass-through entities, brokers and dealers in securities, insurance companies, financial institutions, tax-exempt organizations, small business investment companies, regulated investment companies and foreign taxpayers). This discussion does not address the tax consequences to Holders of Claims who did not acquire such Claims at the issue price on original issue. No aspect of foreign, state, local or estate and gift taxation is addressed.
The following summary is not a substitute for careful tax planning and advice based upon the personal circumstances of each Holder of a Claim or Equity Interest. Each Holder of a Claim or Interest is urged to consult with his, her, or its tax advisors concerning the United States Federal, state, local, foreign, and other tax consequences applicable under the Plan.
A. Consequences to Holders of Allowed Claims in Classes 1, 3, and 4
Pursuant to the Plan, Holders of Allowed Class Claims in Classes 1, 3, and 4 may receive New Common Stock in part in discharge of their Allowed Claims or Interests. Whether or not such a Holder will be required or allowed to recognize gain or loss realized on the exchange of Allowed Claims or Interests for New Common Stock (the “Exchange”) depends on whether the Exchange constitutes a “reorganization” as that term is defined in Section 368 of the Tax Code. This determination, in turn, depends upon whether the Allowed Claim constitutes a “security” for United States federal income tax purposes. Whether an instrument constitutes a “security” is determined based on all the facts and circumstances, including the length of the term of a debt instrument, the security for payment, the creditworthiness of the obligor, the subordination or lack thereof to other creditors, the right to vote or otherwise participate in the management of the obligor, convertibility of the instrument into an equity interest of the obligor, whether payments of interest are fixed, variable or contingent, and whether such payments are made on a current basis or accrued.
Assuming the Holder’s Allowed Claim is treated as a security for United States Federal Income Tax purposes, the Exchange may qualify as a reorganization pursuant to Section 368(a)(1)(E) of the Tax Code and a Holder may not recognize gain or loss on the Exchange, except that a Holder will be required to recognize taxable income to the extent that a portion of the New Common Stock received is allocable to accrued interest on the Allowed Claims exchanged therefor.
A Holder of an Allowed Claim that does not constitute a “security” for United States Federal Income Tax purposes will recognize gain or loss for United States Federal Income Tax

 

33


 

purposes on the Exchange equal to the difference between (i) the amount realized ( i.e., the fair market value of New Common Stock received) in respect of such Allowed Claim (other than amounts allocable to accrued interest) and (ii) such Holder’s adjusted tax basis in such Allowed Claim.
The character of any gain or loss as long-term or short-term capital gain or loss or as ordinary income or loss recognized by a Holder with respect to an Allowed Claim against the Debtors will be determined by a number of factors, including, but not limited to, the following: (a) the tax status of the Holder, (b) whether the obligation from which the Allowed Claim arose constitutes a capital asset of the Holder, (c) whether the obligation from which the Allowed Claim arose has been held for more than one year or was purchased at a discount, (d) whether the Holder is a financial institution or other entity entitled to special treatment under the United States Federal Income Tax laws and (e) whether and to what extent the Holder has previously claimed a bad debt deduction in respect of the obligation from which the Allowed Claim arose. In addition, a substantial amount of time may elapse between the Effective Date and date on which a Holder may receive distributions under the Plan. Both the timing and ultimate amount of Distributions is uncertain, and the delay in Distributions may defer the recognition of gain or loss to Holders. Holders should consult their own tax advisors to determine the United States Federal Income Tax consequences of the consummation of and the receipt of Distributions under the Plan.
B. Consequences to the Debtors
1. Cancellation of Indebtedness Income
Subject to certain exceptions, a debtor recognizes cancellation of debt (“COD”) income upon satisfaction of its outstanding indebtedness equal to the excess of (i) the amount of the indebtedness discharged, over (ii) the issue price of any new indebtedness issued, the amount of cash paid, and the fair market value of any other consideration (including stock of the debtor) given in satisfaction of the indebtedness. As discussed below, there is a bankruptcy exception to the recognition of COD income which will apply to the Debtors in connection with the Plan.
A debtor is not required to include COD income in gross income if the debt discharge occurs under chapter 11 of the Bankruptcy Code. However, under the Tax Code, the debtor must reduce certain tax attributes (in general, first its Net Operating Loss (“NOL”) carryovers and then certain tax credits, capital loss carryovers, the tax basis of its assets, and foreign tax credits) by the amount of COD income excluded from gross income by this exception. As an exception to the order of tax attribute reduction described above, a taxpayer can elect to reduce its tax basis in its depreciable assets first, then its NOL carryovers.
2. Limitation of Net Operating Loss Carryovers
Pursuant to Section 382 of the Tax Code, and subject to certain exceptions discussed below, if there is an “ownership change” with respect to a corporation with NOL carryovers, such corporation will be subject to a limitation on its use of any NOL carryover incurred prior to the ownership change to offset taxable income earned after the ownership change (a “Section 382 Limitation”). Except as discussed below, the Section 382 Limitation on such corporation’s NOL carryover will be equal to the product of (i) the net equity value of all of the corporation’s stock

 

34


 

immediately before the ownership change and (ii) the long-term tax-exempt rate as determined under IRS rules. The long-term tax exempt rate is published monthly by the Treasury Department and is intended to represent current interest rates on long-term tax-exempt debt obligations.
In general, an “ownership change” occurs if the percentage of stock of the corporation owned actually or constructively by one or more “5% shareholders” increases by more than 50 percentage points on any “testing date” (taking into account all relevant adjustments as of the end of a “testing date”) as compared to the lowest percentage of stock of the corporation owned by those 5% shareholders at any time during the statutory “testing period” (generally, the past three years or, if shorter, the period since the last ownership change). Generally, a “testing date” is any date on which there is any change in the ownership of stock that affects the percentage stock ownership of a 5% shareholder. A “5% shareholder” is one who owns at least 5% of the stock of the corporation, and all stock owned by shareholders who are not 5% shareholders is generally treated as being owned by one 5% shareholder.
If the Plan causes an ownership change with respect to the Debtors, then to the extent any NOL carryover and certain other tax attributes allocated to the Debtors are not reduced by the amount of realized COD income and subject to any preexisting Section 382 Limitation on the Debtor’s ability to offset the NOL carryover and such other tax attributes against taxable income, the use of the remaining NOL carryover and such other tax attributes will be subject to the Section 382 Limitation unless the exception in Section 382(a)(5) applies.
If the exchanges contemplated by the Plan qualify for the tax treatment under Section 382(l)(5), the Debtors’ NOL carryover will be available for future use without any Section 382 Limitation (subject to any preexisting Section 382 Limitation and after reduction of the Debtors’ NOL carryover by the Disqualified Interest). If the exchanges do not qualify for the tax treatment under Section 382(l)(5) or the Debtors elect not to utilize Section 382(l)(5), the Debtors’ use of the NOL carryover to offset taxable income earned after the ownership change will be subject to the Section 382 Limitation (as well as any preexisting Section 382 Limitation).
In the Restructuring Agreement, the Debtors agreed to take all reasonable and appropriate steps to attempt to preserve some or all of the NOLs and to structure any transactions contemplated by the Restructuring Agreement and Plan in a manner to preserve NOLs; provided, however, that to the extent that the restructuring set forth in the Restructuring Agreement and Plan will not result in a preservation of some or all of the NOLs, it is expressly understood by and between the parties that the Debtors will move forward with the terms of the Restructuring Agreement and Plan regardless of the potential loss of the NOLs.
3. Alternative Minimum Tax
Alternative minimum tax (“AMT”) must be paid by a corporation when and to the extent that its liability for AMT exceeds its regular tax liability. AMT is equal to 20% of alternative minimum taxable income (“AMTI”) less certain allowable credits. AMTI generally equals regular taxable income, increased or decreased by certain adjustments and preference items.
THE FEDERAL, STATE, LOCAL AND FOREIGN TAX CONSEQUENCES OF THE PLAN ARE COMPLEX AND, IN MANY RESPECTS, UNCERTAIN. THE

 

35


 

FOREGOING IS INTENDED TO BE A SUMMARY ONLY AND, AS SUCH, DOES NOT DISCUSS ALL ASPECTS OF FEDERAL INCOME TAXATION THAT MAY BE RELEVANT TO A PARTICULAR HOLDER OF CLASS 1, 3, AND 4 CLAIMS OR INTERESTS. ALL HOLDERS OF SUCH CLAIMS OR INTERESTS ARE STRONGLY URGED TO CONSULT WITH THEIR OWN TAX ADVISORS REGARDING THE TAX CONSEQUENCES OF THE PLAN THAT ARE RELEVANT TO THEIR PARTICULAR CIRCUMSTANCES.
X. CONCLUSION AND RECOMMENDATION
The Debtors believe that confirmation and implementation of the Plan is preferable to any alternatives because it will provide the greatest chance of maximizing recoveries to Creditors. In addition, alternatives may involve significant delay, uncertainty, and substantial additional administrative costs. The Debtors urge Holders of Claims entitled to vote on the Plan to vote to accept the Plan and to evidence such acceptance by returning their Ballots so they will be received no later than the Voting Deadline.
         
Dated: July 30, 2009        
            Wilmington, Delaware  CIARDI CIARDI & ASTIN
 
 
  /s/ Mary E. Augustine    
  Daniel K. Astin (No. 4068)   
  Anthony M. Saccullo (No. 4141)
Mary E. Augustine (No. 4477)
Carl D. Neff (No. 4895)
919 N. Market Street, Suite 700
Wilmington, Delaware 19801
Tel: (302) 658-1100
Fax: (302) 658-1300
dastin@ciardilaw.com
asaccullo@ciardilaw.com
maugustine@ciardilaw.com
cneff@ciardilaw.com

Counsel for the Debtors  
 
 

 

36